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Volatile Organic Compound Detection And Disease Diagnostics Using DnaFunctionalized Carbon Nanotube Sensor Arrays
Abstract
There is a strong desire for novel chemical sensors that can detect low concentrations of volatile organic
compounds (VOCs) for early-stage disease diagnostics as well as various environmental monitoring
applications. The aim of this thesis work was to address these challenges by developing an “electronic
nose” (e-nose) platform based on chemical sensor arrays capable of detecting and differentiating
between various VOCs of interest. Sensor arrays were fabricated in a field-effect transistor (FET)
configuration with exquisitely sensitive carbon nanotubes (CNTs) as the channel material. The nanotubes
were functionalized with a variety of single-stranded DNA oligomers, forming DNA-NT hybrid structures
with affinity to a wide variety of VOC targets. Interactions between DNA-NTs and VOCs yielded changes in
sensor conductivity that depended strongly on the base sequence of DNA. Arrays of CNT devices were
functionalized with up to ten different DNA oligomers to enable electronic signature readouts of VOC
binding events. DNA-NT responses were processed with pattern recognition algorithms in order to
classify different VOC targets according to their chemical “fingerprints.” This technology was used to
measure VOC biomarkers associated with ovarian cancer and COVID-19 from human fluid media. DNA-NT
arrays measured headspaces VOCs from 58 blood plasma samples from individual people, including 15
with a late-stage malignant form of ovarian cancer, 6 with early-stage malignant cancer, 16 with a benign
form of cancer, and 21 healthy age-matched controls. Statistical techniques based on machine learning
were used to discriminate between the malignant, benign, and healthy groups with 90 – 95% classification
accuracy. Furthermore, all six early-stage samples were correctly identified with the malignant group,
indicating significant progress towards an effective screening method for ovarian cancer. Similar
investigations were conducted on sweat samples procured from patients who had tested positive for
COVID-19 (CoV+) and those who had tested negative (CoV-). Statistical analysis of the DNA-NT responses
to the sweat headspace VOCs revealed highly differentiated clusters associated with the CoV+ and CoVgroups. A binary classifier was constructed using the response data and was estimated to have a 99%
classification success rate, suggesting strong potential for utilizing DNA-NTs for COVID screening. Finally,
DNA-NT arrays were assessed based on various performance characteristics desired for remote
environmental monitoring applications such as pollution monitoring and explosives detection in a
warzone. A series of experiments was conducted to evaluate DNA-NT sensitivity, specificity, and longevity
using mixtures of 2,6-dinitrotoluene (DNT) and dimethyl methylphosphonate (DMMP) to simulate
complex VOC environments. The sensors demonstrated sensitivity to parts-per-billion concentrations of
DNT in a highly concentrated background of DMMP. Moreover, the shelf life of these sensors was
projected on the order of months, making DNA-NTs promising candidates for a wide range of
applications.
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ABSTRACT
VOLATILE ORGANIC COMPOUND DETECTION AND DISEASE DIAGNOSTICS USING DNAFUNCTIONALIZED CARBON NANOTUBE SENSOR ARRAYS
Christopher E. Kehayias
A. T. Charlie Johnson

There is a strong desire for novel chemical sensors that can detect low concentrations of
volatile organic compounds (VOCs) for early-stage disease diagnostics as well as various
environmental monitoring applications. The aim of this thesis work was to address these
challenges by developing an “electronic nose” (e-nose) platform based on chemical sensor
arrays capable of detecting and differentiating between various VOCs of interest. Sensor
arrays were fabricated in a field-effect transistor (FET) configuration with exquisitely
sensitive carbon nanotubes (CNTs) as the channel material. The nanotubes were
functionalized with a variety of single-stranded DNA oligomers, forming DNA-NT hybrid
structures with affinity to a wide variety of VOC targets. Interactions between DNA-NTs
and VOCs yielded changes in sensor conductivity that depended strongly on the base
sequence of DNA. Arrays of CNT devices were functionalized with up to ten different
DNA oligomers to enable electronic signature readouts of VOC binding events. DNA-NT
responses were processed with pattern recognition algorithms in order to classify different
VOC targets according to their chemical “fingerprints.” This technology was used to
measure VOC biomarkers associated with ovarian cancer and COVID-19 from human fluid
media. DNA-NT arrays measured headspaces VOCs from 58 blood plasma samples from
individual people, including 15 with a late-stage malignant form of ovarian cancer, 6 with
v

early-stage malignant cancer, 16 with a benign form of cancer, and 21 healthy age-matched
controls. Statistical techniques based on machine learning were used to discriminate
between the malignant, benign, and healthy groups with 90 – 95% classification accuracy.
Furthermore, all six early-stage samples were correctly identified with the malignant group,
indicating significant progress towards an effective screening method for ovarian cancer.
Similar investigations were conducted on sweat samples procured from patients who had
tested positive for COVID-19 (CoV+) and those who had tested negative (CoV-).
Statistical analysis of the DNA-NT responses to the sweat headspace VOCs revealed
highly differentiated clusters associated with the CoV+ and CoV- groups. A binary
classifier was constructed using the response data and was estimated to have a 99%
classification success rate, suggesting strong potential for utilizing DNA-NTs for COVID
screening. Finally, DNA-NT arrays were assessed based on various performance
characteristics desired for remote environmental monitoring applications such as pollution
monitoring and explosives detection in a warzone. A series of experiments was conducted
to evaluate DNA-NT sensitivity, specificity, and longevity using mixtures of 2,6dinitrotoluene (DNT) and dimethyl methylphosphonate (DMMP) to simulate complex
VOC environments. The sensors demonstrated sensitivity to parts-per-billion
concentrations of DNT in a highly concentrated background of DMMP. Moreover, the
shelf life of these sensors was projected on the order of months, making DNA-NTs
promising candidates for a wide range of applications.
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CHAPTER 1: Overview of the Thesis

There is an ever-increasing need for vapor-phase chemical sensors in biomedical
applications including early-stage disease diagnostics or environmental monitoring
applications such as pollution detection. Until recently, few technological advancements
have been able to effectively respond to these needs because such applications demand
high sensitivity to a wide variety of volatile organic compounds (VOCs) as well as fast
response times and long sensor lifetimes. The emergence of nano-bio hybrid materials has
stirred much excitement within the chemical sensing community due to the combined
sensitivity of novel nanomaterials such as carbon nanotubes and graphene with various
biomolecules with tunable affinities towards specific or a wide range of target vapor
analytes. Electronic systems based on nano-bio materials are uniquely well-suited for
chemical sensing applications due to their exquisitely high surface-to-volume ratios,
ensuring that electronic transport activity occurs in close proximity to chemical binding
events that take place on the material surface. This work focuses on the development of an
electronic nose system based on DNA-functionalized carbon nanotube field-effect
transistors and the evaluation of this system for ovarian cancer diagnosis of human blood
plasma samples, COVID-19 screening based on human sweat, and various performance
characteristics desirable in environmental monitoring applications.
Chapter 2 of this thesis discusses the importance of detection systems based on
olfaction and motivates the development of vapor sensing technology due that can operate
1

at the same proficiency as mammalian olfactory systems. Electronic nose systems based
on DNA-functionalized carbon nanotube (DNA-NT) vapor sensors are introduced. The
electronic properties of carbon nanotubes are discussed, motivating their use in chemical
sensing applications due to their remarkable sensitivity. The field-effect transistor (FET)
architecture of DNA-NT sensor arrays is presented and an overview of their operability is
provided. Chemical functionalization of the nanotubes (NTs) via single-stranded DNA is
covered, as is the interaction between target VOCs and the DNA-NT hybrid structures. The
Hill-Langmuir theory of binding dynamics is proposed as a model for VOC binding events
and is used to explain the relationship between variations in target concentrations and
DNA-NT conductivity. Finally, statistical analysis techniques based on two machine
learning algorithms, principal component analysis (PCA) and linear discriminant analysis
(LDA), are summarized with more vigorous derivations found in the Appendix of this
thesis. Binary classification based on receiver operating characteristics (ROCs) are also
introduced.
Chapter 3 describes electrode fabrication processes for FET arrays based on
photolithography as well as procedures for deposition of the carbon nanotubes across the
FET channels and chemical functionalization via single-stranded DNA. Electrical
characterization of DNA-NT arrays is presented. General experimental procedures and data
acquisition protocols are also introduced, as are data processing techniques. An overview
of the equipment used in each experiment is also included.
Chapter 4 discusses the challenge of early-stage diagnosis of ovarian cancer and
motivates the development of a reliable screening technique to improve the survivability
2

of patients who develop this disease. A collaboration between Penn Hospital, the Johnson
Group, the Penn Vet Working Dog Center and the Monell Chemical Senses Center is
presented with the aim of analyzing VOCs from human blood plasma associated with
ovarian cancer patients as well as healthy controls using three different approaches: (1)
analytical chemistry using gas chromatography / mass spectrometry to identify differences
in VOC composition between diseased and healthy blood; (2) training of sniffer dogs to
identify blood samples as diseased or healthy based on their odors; and (3) using DNA-NT
arrays to differentiate between VOC signatures associated with cancerous and noncancerous individuals. This chapter focuses on the third approach. DNA-NT measurements
of headspace VOCs from pooled plasma and plasma from individuals are described. Data
processing and classification of the sensor response data using LDA is presented. Crossvalidation techniques are introduced to test the statistical robustness of the LDA-based
classifiers. Lastly, modifications to the experimental procedure in order to accommodate
challenges measure plasma VOCs are discussed.
Chapter 5 introduces a collaboration between the Johnson Group and Rohinton
Mehta’s group from X Development with the aim of evaluating DNA-NT sensitivity,
ability to detect low-concentration targets in a complex background, response times, and
longevity. Experiments involving a newly fabricated DNA-NT array are described in
which array is exposed to multiple different concentrations of 2,6-dinitrotoluene (DNT), a
compound known to have a relatively low vapor pressure. Additional experiments
involving parts-per-billion concentrations of DNT diluted in a highly concentrated
background of dimethyl methylphosphonate (DMMP) are discussed. Similar experiments
3

are presented in which the fresh DNA-NT array is replaced with one that was prepared four
months prior. Special data processing techniques using boxcar smoothing to assist in
resolving low-concentration signals are introduced. Conclusions are made is assessment of
the DNA-NT performance in all experiments.
Chapter 6 discusses the deadly implications of the new COVID-19 disease and
drawbacks of current screening procedures. An investigation involving DNA-NT
discrimination of VOCs from human sweat procured from COVID-positive (CoV+) and
COVID-negative (CoV-) volunteers is described. LDA processing of the ensuing response
data is presented, revealing promising separation between the CoV+ and CoV- groups.
Sensitivity and specificity estimates are presented for a binary classifier based on the LDA
results, as are estimates of the overall classification accuracy using a ROC curve.
Chapter 7 includes a summary of the thesis, along with a discussion of future
prospects and developments needed to convert our apparatus into a reliable technology for
clinical or commercial use.
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CHAPTER 2: Principles of Electronic Nose Chemical
Sensors

In this chapter, we discuss the motivation and advantages of developing an
electronic nose (e-nose) technology to explore volatile signatures appropriate for a diverse
set of applications. This technology can probe the relatively untapped wealth of
information found in chemical signatures based on volatile organic compounds (VOCs)
produced from various biological and industrial sources, potentially leading to new and
compelling applications.
Section 2.1 describes the e-nose concept and its advantages over other chemical
sensing techniques. We introduce an e-nose based on a large array of diversified chemical
sensors that produce a unique olfaction response to a given target analyte. The sensing
medium is a combination of highly sensitive carbon nanotubes and single-stranded DNA
that induces an affinity to a wide variety of VOCs.
In Section 2.2, we discuss the properties of carbon nanotubes. These are
nanostructures that are exquisitely sensitive to changes in their local environment, making
them ideal candidates for chemical sensing applications. Section 2.3 outlines how we
combine carbon nanotubes with field effect transistors to form chemical sensors with an
electronic readout. A “chemical gating” mechanism is proposed as the interaction between
target analytes and the carbon nanotubes that produces a measurable electrical response.
Chemical functionalization with single-stranded DNA is also described.

5

Section 2.4 introduces the Hill-Langmuir model that describes binding dynamics
between chemical receptors and target species. Finally, Section 2.5 outlines basic
principles of machine learning algorithms used to perform pattern recognition and
statistical analysis on our e-nose response data to identify the chemical signatures of
various VOCs of interest.

2.1 Introduction to Electronic Nose Systems

The important role olfaction plays in the survival of living creatures can hardly be
overemphasized. One of nature’s oldest senses, olfaction enables a lifeform to detect and
characterize traces of molecules in the air that indicate the presence of food, danger, or
potential mates.1 In nature, many such molecules are volatile organic compounds (VOCs)
produced metabolically by plants and animals. VOCs are compounds that have relatively
high vapor pressure and low water solubility for standard temperatures.2 Generations of
evolution have shaped olfaction mechanisms in a variety of organisms into highly
successful chemical sensing systems able to discriminate between VOCs with remarkable
precision.3-4
Compared to countless advancements inspired by our visual and auditory systems,
progress towards a technological equivalent of a nose has been relatively slow. Currently,
our most reliable chemical vapor sensor is the canine. Dogs’ noses have about 300 million
olfactory receptors represented by 1100 unique olfactory receptor proteins (ORPs)
compared to six million sensors and 350 ORPs for humans, and thus dogs are able to
6

identify a much wider variety of VOC targets.5 Dogs’ noses are also 10,000 – 100,000
more sensitive than our own, able to detect VOCs at sub-parts per trillion levels.6-7 Sniffer
dogs are highly successful in applications ranging from tracking odor signatures of missing
personnel to detecting explosives or narcotics. However, using sniffer dogs in analytical
applications is not as ideal. Unlike scientific instruments, a sniffing dog requires long-term
professional training and its chemical “readout” is an anecdotal interpretation of its
behavior. Often, the dog’s response is ineffectively communicated to its trainer and can be
influenced by fatigue or short attention span.8 Moreover, it is practically impossible to
determine which chemical compounds in particular are triggering the dogs’ responses.8
A more scientifically robust approach is found in today’s electronic nose (e-nose)
sensors. An e-nose is a device that incorporates electronic sensor arrays with pattern
recognition systems to detect and discriminate between various odors.9 The architecture of
e-nose systems is inspired by mammalian olfaction, making use many different types of
cross-selective olfactory receptors that produce diversified electronic outputs upon
exposure to a broad range of VOC analytes.9-10 These outputs are then recorded in a
computer database and processed using pattern recognition and statistical analysis
algorithms. The first e-nose was developed in 1982 based on three varieties of
semiconductor transducers with broad, overlapping chemical selectivity.11 The sensing
material was composed of conductive carbon black coatings coupled with insulating
polymers. Adsorption of VOCs would cause the material to swell, causing a measurable
decrease in its conductivity. Unfortunately, these early e-nose sensors could only
differentiate between certain hydrophilic and hydrophobic molecules – nevertheless, their
7

emergence sparked the development of increasingly sophisticated e-nose designs with
recent

progress

towards

explosives

detection

and

environmental

monitoring

applications.12-14
In more recent years, e-nose gas sensors have also become popular candidates as
detectors for VOC disease biomarkers.15-16 Disease monitoring based on VOC biomarkers
poses the additional challenge that the target molecules are very complex chemically.17 To
differentiate between these targets requires sensing materials that can accommodate such
complexity. Fortunately, many biomolecular compounds are available that have natural
affinity to biomarkers. These biomolecules can either be borrowed from nature, such as
DNA or protein antibodies produced by the body, or engineered to serve a particular
function.18-19 In addition, biomolecules can be chemically linked to electronic materials
such as novel nanomaterials that possess exquisitely sensitive electronic properties.18, 20
Nanomaterials are a natural choice for chemical sensing applications because they exhibit
large surface-to-volume ratios and are atomically thin, thus confining charge carrier
transport to the material surface where interactions with the environment take place.21
This thesis work makes use of an e-nose system based on arrays of single-walled
carbon nanotube field-effect transistors (NTFETs). A field-effect transistor (FET) is a
three-terminal device in which the conduction between a source and a drain electrode pair
is modulated by a voltage applied to a third gate electrode. A special electrode layout for a
NTFET sensor array was designed to accommodate multiple sensor types that would
respond simultaneously to target analytes (Figure 2.1a). A given array comprises 100
NTFETs divided into ten groups of ten sensors each (Figure 2.1b). Each group is
8

chemically functionalized with an oligomer of single-stranded DNA with a different base
sequence to induce differential affinity to a wide range of VOC targets.22-23 The sensor
arrays are exposed to target biomarkers of interest using a home-built gas-delivery system.
VOC analytes that adsorb onto the DNA-nanotube (DNA-NT) hybrid structures elicit
electrical responses from the CNTs that are recorded and stored in a computer. The data is
later processed using pattern-recognition algorithms to identify informative features useful
for discriminating between different VOCs.

Figure 2.1. (a) Electrode layout for an array of 100 NTFETs partitioned into ten groups of ten
devices each. The ten groups are arranged in staggered columns, facilitating individual
functionalization with ten different DNA oligomers without cross-contamination between groups.
Source and drain electrodes are positioned at the top of each column (one region circled in red).
Directly below are square contact pads for external measurement. (b) Microscope image of ten
DNA-NT devices composed of ten drain electrodes and one common source electrode arranged
in an interdigitated finger configuration. (c) Scanning electron microscopy image of a channel
reveals a network of interspersed CNTs between a source-drain electrode pair.

9

2.2 Principles of Carbon Nanotubes

2.2.1 Overview of Single-Walled Carbon Nanotubes
Single-walled carbon nanotubes (SWCNTs) are carbon allotropes with tubular
structures that have diameter length scales on the order of nanometers. Each SWCNT is
composed of a single-atomic layer of sp2-hybridized carbon atoms arranged in a hexagonal
“honeycomb” lattice. We can immediately draw a similarity to the structure of graphene
which is a planar lattice of carbon atoms also arranged in a honeycomb lattice.24 The
geometry of a SWCNT can be imagined by rolling a graphene sheet along a certain axis
into a cylinder with seamlessly-bonded carbon atoms forming the surface. In order to
preserve the lattice periodicity on the SWCNT, only certain choices for the rolling direction
are allowed. This direction is called the chiral vector and the discrete set of geometric
conformations for SWCNTs are known as chiralities.
It is possible to obtain multi-walled carbon nanotubes (MWCNTs) in which several
coaxial SWCNTs of varying diameters are merged into a single structure.25 However, I
only used SWCNTs throughout my PhD research – hence, I will refer to SWCNTs simply
as CNTs for the remainder of this dissertation.

2.2.2 Semiconducting Carbon Nanotubes
The dimensions and chirality of a CNT play crucial roles in determining its
electronic properties. Given two linearly independent translation vectors on the graphene
⃑ , is represented by
⃑ 𝟏 and 𝒂
⃑ 𝟐 , the chiral vector of a CNT, ⃑𝑹
lattice, 𝒂
10

⃑𝑹
⃑ = 𝑛𝒂
⃑ 𝟏 + 𝑚𝒂
⃑𝟐

(2.2.1)

where n and m are integers. The chirality of a given CNT is commonly represented using
the shorthand (𝑛, 𝑚). Conventionally, n is positive with 𝑛 ≥ 𝑚. Two special cases include
the “zigzag” chirality, where 𝑚 = 0, and “armchair” CNTs in which 𝑛 = 𝑚 (Figure 2.2).
The diameter, d, of a (𝑛, 𝑚) CNT is given by the following formula:

𝑑 = 𝑎√3(𝑛2 + 𝑛𝑚 + 𝑚2 )/𝜋

(2.2.2)

where 𝑎 = 1.42 Å is the interatomic distance between adjacent carbon atoms.25

Figure 2.2. The hexagonal “honeycomb” lattice of the graphene structure (left) can be
⃑ 𝟏 and 𝒂
⃑ 𝟐 . Single-walled carbon
mathematically represented by the translation vectors 𝒂
nanotubes (SWCNTs) can be constructed by rolling ribbon-like subsets of this lattice (indicated
⃑⃑ | = |𝒏𝒂
⃑ 𝟏 + 𝒎𝒂
⃑ 𝟐 | where n and m are
by the dashed edges) into cylinders with circumference |𝑹
integers. Chiral vectors are shown for a (8, 0) “zigzag” nanotube (blue) and a (5, 5) “armchair”
nanotube (yellow).
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The chirality of a CNT can indicate whether it behaves as a metal or semiconductor.
Semiconducting CNTs are far more desirable for use in our e-nose because their
conductances vary drastically when exposed to nearby VOC analytes compared to only
negligible changes for metallic CNTs. A (𝑛, 𝑚) CNT is metallic if 𝑛 = 𝑚 or quasi-metallic
with a very small bandgap if 𝑛 − 𝑚 is a multiple of 3 with 𝑛 ≠ 𝑚 and 𝑛𝑚 ≠ 0; a
semiconducting CNT results in all other cases.25-26
The vapor sensors used in this thesis work were fabricated using a solution of 98%
semiconducting CNTs suspended in an aqueous solution purchased from NanoIntegris Inc.
(Quebec, Canada). From an electronic transport point of view, these CNTs are essentially
one-dimensional structures since they are quantum-confined spatially in two dimensions.27
An elementary result from solid state physics reveals that the electronic density of states,
𝐷(𝐸), for a one-dimensional potential takes the following form:

𝐷(𝐸) =

1 2𝑚𝑒
ඨ
(𝐸 − 𝐸𝑐)−1/2
2𝜋 ℏ2

(2.2.3)

where 𝑚𝑒 is the electron mass, 𝐸 is its energy and 𝐸𝑐 is the minimum energy of a given
subband.25 The 1/√𝐸 relationship yields a series of discontinuities in

𝑑𝐷(𝐸)
𝑑𝐸

called Van

Hove singularities that indicate energies within a subband that have a large number of
available states (Figure 2.3). The first Van Hove singularity below the Fermi energy
coincides with the edge of the valence band which consequently corresponds to a large
number of available hole states (the CNTs used in this work are p-type so holes are the
majority charge carrier). The number of holes occupying these states can be increased with
an external electric field until a generated hole current is well above the noise threshold of
12

roughly 1 pA. This phenomenon is enabled by the field effect which will be described in
the following section.

Figure 2.3. The density of electronic states 𝑫(𝑬) for a semiconducting (6,5) CNT with a diameter
of approximately 1 nm. As a consequence of this nanoscale confinement, the conduction and
valence bands are divided into subbands that take the form 𝑫(𝑬) ∝ 𝟏/√𝑬. A series of Van Hove
singularities occur at energies where

𝒅𝑫(𝑬)
𝒅𝑬

diverges. These are energies for which a large

number of electronic states are available per unit energy. This figure was adapted from
http://www.photon.t.u-tokyo.ac.jp/~maruyama/kataura/kataura.html.

2.3 Carbon Nanotube-Based Sensor Arrays

2.3.1 Field and Chemical Gating of Carbon Nanotube Field-Effect Transistors
The e-nose sensor arrays utilize semiconducting CNTs in a field-effect transistor
(FET) configuration. CNTs are deposited between source and drain electrodes patterned
13

onto Si/SiO2 substrates, forming a NTFET (Figure 2.4a). A fixed source-drain bias (VSD )
is applied to generate a hole current (ISD ) through the NTFET channel which is measured
in real time with an ammeter. A gate potential (VG ) is simultaneously applied to the
underside of the substrate. The Si layer is heavily p-doped which effectively allows charge
carriers to transport through the material as they would in a conductor. Hence, the holes
near the CNT layer are capacitively coupled to the gate potential with the oxide layer in
between serving as a dielectric. A negative gate potential will drive electrons to occupy the
Si layer near the oxide which draws holes from the source electrode to match the change
in opposing charge. The additional holes increase the local hole concentration, ultimately
increasing the conductivity of the p-type CNTs. Similarly, a positive VG will deprive the Si
layer of electrons, thus depleting the local hole concentration near the CNTs and ultimately
decreasing the overall device conductivity. This is demonstrated in an I − VG characteristic
where ISD for an NTFET is measured as a function of a varying VG (Figure 2.4b).

Figure 2.4. (a) A semiconducting CNT is contacted by a source and a drain electrode on a Si/SiO2
substrate. A source-drain bias, 𝐕𝐒𝐃 , generates a current, 𝐈𝐒𝐃 , through the NTFET channel. This
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current is modulated by a gate potential 𝐕𝐆 , applied to the underside of the p-doped Si layer. (b)
𝐈 − 𝐕𝐆 characteristic of a single NTFET depicting the source-drain current as 𝐕𝐆 is swept from
−𝟐𝟎𝐕 to +𝟐𝟎𝐕 and back to −𝟐𝟎𝐕 as indicated by the blue arrows. The discrepancy between the
forward and reverse sweeps is due to a hysteresis effect.28

2.3.2 DNA Functionalization of NTFETs
NTFET conductance is also affected by VOC analytes in close proximity to the
CNTs via “chemical gating.” Though the mechanism is not fully understood, it is believed
that certain VOCs will either donate or accept electrons to or from the CNTs, varying the
local charge carrier concentration and thus causing a shift in ISD from its baseline value.29
Other VOCs are thought to dissociate in the presence of an interfacial water layer, leaving
behind charged molecules that vary the hole density due to electrostatics.29
The sp2-hybridized CNT structure offers a lacking diversity of interactions with
VOCs, limiting the range of detectable VOCs.30 Hence, the CNTs are functionalized with
single-stranded DNA oligomers of a particular base sequence that introduce binding sites
for chemical sensing.30 DNA oligomers adhere onto CNT sidewalls via π – π stacking
interactions, forming DNA-NT hybrid structures. This is a relatively strong chemical
attraction that does not interfere with the covalent carbon-carbon bonds of the CNT, thus
preserving the desirable electronic sensitivity of the overall structure.31 Furthermore, the
DNA oligomers assume sequence-specific conformations with loop and hairpin structures
that enable diversified interactions between VOC analytes and the DNA-NT structures.30,
32-34

The sensor arrays used in this research were functionalized with ten DNA oligomers

21 – 24 bases long (see Chapter 3, Table 3.1), offering a vast wealth of geometrical and
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chemical complexity that is similarly enjoyed by olfactory receptor proteins found in
nature. The base sequences of these oligomers are random, though in principle they can
also be engineered to have targeted affinities towards certain types of VOC analytes of
interest.22-23 Moreover, customized oligomers of single-stranded DNA are easily accessible
and can be purchased inexpensively from biotechnology vendors such as ThermoFisher
(Waltham, MA) for roughly one US dollar per base.
For a typical experiment, a DNA-NT array is exposed to a mixture of VOC analytes
and water vapor diluted in nitrogen gas. Based on thermodynamics studies of similar
sensing mechanisms, it is hypothesized that the VOCs are solubilized by water molecules
that form an interfacial layer with the DNA structures, enabling an interaction between the
analytes and the DNA (Figure 2.5a).35-36 The VOCs can acquire a charge via dissociation
or ionization, or possibly by exchanging electrons with the DNA-NT hybrid structure. The
DNA-NT fabrication process is designed to limit the DNA functionalization layer to
nanoscale thickness, ensuring that target binding events are in close proximity to the CNT.
The result is an amplified electrostatic interaction between the charged VOCs and the
CNTs, causing measurable shifts in device currents from baseline. Earlier investigations
demonstrated that propionic acid, a known proton donor, evoked positive shifts in DNANT currents from baseline,30 suggesting that a negatively-charged layer of deprotonated
propionic acid ions evoked an increase in CNT hole concentration (Figure 2.5b).30 The
same study also demonstrated that dimethyl methylphosphonate (DMMP), a strong
electron donor,37 elicited negative DNA-NT current responses (Figure 2.5c).
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Figure 2.5. (a) A NTFET, depicted by a single CNT for simplicity. The CNT is functionalized with
a single-stranded DNA oligomer of a particular base sequence (blue and green structure) forming
a DNA-NT hybrid material. Target VOCs (red) interact with DNA binding sites and are adsorbed
onto the DNA-NT. (b) A single DNA-NT sensor is exposed to a two-minute pulse of hydrated
propionic acid. A positive fractional current response ensues, presented as ∆𝐈/𝐈𝟎 where 𝐈𝟎 is the
baseline current. The DNA-NT is subsequently refreshed with nitrogen gas at the same relative
humidity to remove desorbing VOCs, essentially recovering the device current to baseline. (c)
The same DNA-NT was exposed to dimethyl methylphosphonate (DMMP) in the same manner,
which elicits a negative shift in current relative to baseline.

2.4 Hill-Langmuir Binding Dynamics

The binding interaction between single-stranded DNA and target VOCs is
analogous to the binding dynamics of certain protein complexes in which ligand molecules
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link to one or more receptors on a biomolecule to activate a particular biological function
such as various types of molecular machinery within a living cell.38-42 The physical
mechanism of such systems can be modeled using Hill-Langmuir analyte binding dynamics
inspired by a simplified system of ligands occupying substrate-dwelling receptors or
binding sites (Figure 2.6). In our case, the ligands are VOCs occurring at a fixed
concentration, c, which is large enough such that VOC binding events cause a negligible
decrease in c.

Figure 2.6. An array of receptors (yellow) is exposed to VOC ligands (blue) at a fixed
concentration. Some of the ligands bind with receptors to form receptor-ligand protein
complexes.

Once a ligand is bound to a receptor, the substrate’s affinity for binding another
VOC depends on the cooperativity of binding, n. Positively cooperative binding occurs
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when n > 0 in which one adsorbed ligand increases the substrate’s affinity while negatively
cooperative binding occurs for n < 0 in which the affinity decreases. The binding is said to
be noncooperative for n = 0 if the affinity is independent of already-bound ligands. The
fractional occupancy, θ, is defined as the fraction of receptors with bound ligands. When
the system is in thermal equilibrium, θ will reach a steady-state value given by the Hill
equation:
(𝑐/𝐾𝑎 )𝑛
𝜃=
1 + (𝑐/𝐾𝑎 )𝑛

(2.4.1)

where 𝐾𝑎 is the VOC concentration for which half the binding sites are occupied and n is
the Hill coefficient describing the cooperativity of binding. Ka and n are generally obtained
experimentally by fitting chemical response data to (2.4.1) for multiple values of c (Figure
2.7).

Figure 2.7. Hypothetical Hill-Langmuir curves outline the relationship between the fractional
occupancy, θ, and the ligand concentration, c, for two different values of the Hill coefficient, n.
Ka = 1 µM for both curves, the concentration at which θ is equal to one half. The colored dots
represent experimentally obtained values from which Ka and n are extrapolated.
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DNA-NT responses in equilibrium (i.e. responses that reach a stable value) are proportional
to θ since ∆I/I0 depends on the number of adsorbed VOCs. Thus, a given DNA-NT’s
sensitivity to changes in VOC concentration is strongly related to the mutual affinity
between the DNA and the VOCs which is reflected by Ka and n.

2.5 Introduction to Machine Learning Algorithms
As was discussed in Section 2.1, an electronic nose consists of an array of
chemically diverse sensors that can discriminate between a vast set of VOCs. Ideally, each
DNA oligomer contributes some orthogonal information about a target odor signature that
enhances the discrimination power, or “chemical resolution,” of the e-nose. Thus, there is
an apparent advantage for e-nose systems that incorporate a large number of distinct sensor
types.43-44 A consequence of this, however, is that the ensuing high-parameter sensor output
is necessarily complex, making it challenging to extract useful information out of it using
conventional data analysis techniques. First-principles investigations of the system’s
behavior are only possible for drastically simplified models. Meanwhile, graphical
visualization is generally fruitless because DNA oligomers have largely overlapping
selectivity, thus any informative features are generally obscured by high parameter
correlation. A specialized statistical approach is needed to analyze the NTFET response
outputs.
Fortunately, there are numerous computational tools available for constructing
predictive models in exploratory data analysis. Principal component analysis (PCA) and
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linear discriminant analysis (LDA) are two such algorithms that we have used to analyze
NTFET array outputs. Both PCA and LDA are linear algebra-based techniques used to
identify patterns in high-dimensional data sets. In doing so, these algorithms can represent
the original data with reduced dimensionality, keeping the most important discriminatory
features. The following sections will review the mathematical foundations of PCA and
LDA.

2.5.1 Principal Component Analysis (PCA)
Principal Component Analysis (PCA) is an unsupervised statistical procedure that
performs an orthogonal linear transformation on a set of observations of possibly correlated
variables to convert them into a set of values represented by linearly uncorrelated variables
called principal components.45-46 This is essentially a change of basis onto a new coordinate
system such that the first principal component represents the direction with the greatest
variance when scalar projections of the data lie on this axis. Subsequent principal
components are associated with lower variances in descending order. Any correlation
between variables in the original data representation indicates redundancy, and thus the
data can be simplified by replacing the correlated variables with a single variable. In this
way, significant trends and features can be revealed using only a few components.
Figure 2.8 shows a simulated set of 1,000 DNA-NT responses to a given type of
VOC. The points are drawn randomly from a bivariate gaussian distribution to represent
variations in signal due to differences in DNA-NT sensitivities as well as sources of
random noise. For simplicity, only Seq1 and Seq2 responses are shown. PCA is an
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unsupervised algorithm in that no prior knowledge of class distinction between data points
is assumed. The first principal component, PCA1, maximizes the variance of the overall
data and is associated with the measurement signal while the orthogonal axis, PCA2,
represents the weakest correlation and is associated with signal noise. Effectively, the first
principal component is the axis which maximizes the signal-to-noise ratio for the
measurements. A more detailed mathematical explanation of PCA can be found in
Appendix A.1.

Figure 2.8. A simulated set of 1,000 DNA-NT responses are drawn randomly from a bivariate
Gaussian distribution. Only Seq1 and Seq2 responses are shown for simplicity. The first
principal component, PCA1, maximizes the variance of the overall data set and is associated with
the signal while the orthogonal axis, PCA2, represents the weakest correlation and is associated
with signal noise.
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2.5.2 Linear Discriminant Analysis (LDA)
Like PCA, LDA performs a linear transformation on a dataset to reduce its
dimensionality and facilitate pattern recognition. LDA is a supervised algorithm that finds
directions (called linear discriminants) that maximize separation between two or more data
classes. This is achieved when the separation between the centroids of known class
distributions is greatest when compared to the measure spread for the two clusters. Figure
2.9 illustrates two hypothetical distributions of Seq1 and Seq2 responses to two different
types of VOCs. The measurements would clearly overlap significantly if projected onto
either the horizontal or the vertical axis which would result in poor separation between the
clusters. The optimal separation is expressed by projections onto the axis designated by the
first linear discriminant (see Appendix A.2 for the mathematical foundations for LDA).

Figure 2.9. A simulated two-parameter data set with two classes of Gaussian-distributed data
(red and blue). The distributions overlap significantly along the horizontal and vertical axes.
Using LDA, one can discover a rotated representation of these axes (shown as the diagonal
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lines). The distributions on the left show histograms of the data projected onto the
corresponding axis, resulting in optimized class separation.

A predictive classifier can be constructed by fitting LDA parameters to an existing
set of class-labeled data points. A multivariate normal distribution is used to model each
class distribution which assigns a probability to any new data point. The estimated
classification of the new point is selected based on the class for which this probability is
the highest.

2.5.3 Receiver Operating Characteristics
The accuracy of a predictive classifier model can be validated using a receiver
operating characteristic (ROC) curve. Given a collection of measurements of two distinct
observables, a ROC curve provides an estimate of the classification accuracy of the model
by comparing the false positive rate (FPR) and true positive rate (TPR) for all possible
measurement values. This is represented visually in Figure 2.10, where two overlapping
distributions of measurements for a positive and negative signal (Figure 2.10a) are
distinguished by sweeping a measurement parameter, ζ, and computing the relationship
between the FPR and TPR (Figure 2.10b). The area under the curve (AUC) formed by this
relationship determines the probability of correctly classifying a measurement picked at
random as negative or positive. This AUC is an estimate of the overall accuracy of the
classifier model.
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Figure 2.10. Two overlapping distributions of measurements for an imagined two-class system
are distinguished for every possible value of the measurement parameter, ζ. The colored areas
represent the true negative (TN), true positive (TP), false negative (FN), and false positive (FP)
regions for a given ζ. (b) An imagined ROC curve shows the relationship between the false
positive rate (FPR) and the true positive rate (TPR). The area under this curve (AUC) determines
the probability of correctly classifying a measurement picked at random. The dashed line
represents the ROC when the two distributions are perfectly indistinguishable.
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CHAPTER 3: Device Fabrication, Experimental Methods,
and Data Processing

In Section 3.1, we discuss the fabrication process of DNA-NT arrays and how we
utilize them in experiments. Our processes are designed to yield high-yield, ultrasensitive
chemical sensors using standard and easily reproducible techniques. We fabricate sourcedrain electrode pairs on silicon-based substrates using photolithography. A CNT network
is deposited across the FET channels, each chemically functionalized with single-stranded
DNA of a particular base sequence. DNA-NT arrays are characterized for quality and
sensitivity using I-VG sweeps.
Section 3.2 outlines the vapor delivery system used to expose DNA-NT arrays to
target VOCs. A home-built experimental setup was is used to house multiple VOC sources
at a time. A series of computer-automated valves and mass flow controllers deliver the
volatile headspace of these samples to a specially constructed sensor chamber according to
a computer-automated protocol. The sensor chamber is fitted with contacts that enable
rapid, high-precision measurements of 100 DNA-NT currents in real time.
Section 3.3 describes the typical procedure for collecting DNA-NT chemical
signature data as well as data analysis methods. DNA-NT arrays are generally exposed to
a series of pulses of target VOCs from a given sample. A refresh period follows each pulse
to remove analytes from the system, returning DNA-NTs to a quiescent state. The current
responses to each exposure are computed as the fractional current shift relative to a baseline
curve that is fitted to the response data using linear interpolation. Baseline-fitted responses
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from all DNA-NTs functionalized with the same sequence of DNA are averaged together
to produce a representative response for that sensor type.

3.1 Fabrication and Characterization of NTFET Sensor Arrays

3.1.1. Photolithographic Patterning of Electrode Arrays
A standard photolithographic procedure is implemented to fabricate FET electrodes
using the Quattrone Nanofabrication Facility at the Krishna P. Singh Center (see Appendix
C for a full detailed description of the procedure). The substrates are standard boron-doped
<100> silicon wafers, approximately 10 cm (4 inches) in diameter and 500 – 550 µm in
thickness. Each Si wafer has 285 nm layer of polished dry thermal oxide (SiO 2). Prior to
electrode patterning, 15 nm of Al2O3 is deposited via atomic layer deposition (ALD) on a
Si/SiO2 wafer (Figure 3.1). This is done because CNTs have improved adhesion to Al2O3
over the bare SiO2 surface. The wafer is then coated with a positive photoresist, an organic
material that degrades when exposed to certain wavelengths of light. The wafer is placed
in a mask aligner where ultraviolet light is passed through a photomask, exposing the
photoresist only in selected regions. Any exposed resist is dissolved away with a developer,
leaving behind bare substrate. The entire wafer is then coated with 5 nm Cr followed by 40
nm of Au using an electron beam physical vapor deposition (EBPVD) system. The Cr layer
is necessary to increase the adhesion between the oxide and the Au layer. All remaining
photoresist is dissolved by submerging the wafer into a solvent containing 1-methyl-2-
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pyrrolidinone. Whatever metal not in direct contact with the wafer is lifted off and
removed, thus leaving behind the desired electrode pattern.

Figure 3.1. A standard photolithography process is used to define electrode features on a Si/SiO2
substrate. Starting at the upper-left diagram, a layer of Al2O3 (shown in blue) is deposited onto
the substrate to increase its affinity to CNTs. Positive photoresist is then spin-coated uniformly
onto the substrate. A photomask is placed between the substrate and a source of ultraviolet light,
blocking selected regions from being exposed. Any photoresist exposed to the light is degraded
and removed. A layer of Au is evaporated onto the entire wafer. The remaining photoresist is
lifted off, leaving behind metallized regions in the desired pattern.

Following a successful lithography process, the wafer is diced into individual chips, each
containing a full set of electrodes for a single DNA-NT array.
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3.1.2 Deposition and Functionalization of CNTs
The vapor sensors used in this thesis work were fabricated using a solution of 98%
semiconducting CNTs suspended in an aqueous solution purchased from NanoIntegris Inc.
(Quebec, Canada). CNTs dissolved in pure water will tend to aggregate together into bulk
carbon precipitate that exhibits metallic rather than semiconducting properties. To prevent
this, the solution contains a water-soluble surfactant that keeps the CNTs separated. The
CNTs themselves are grown using chemical vapor deposition and placed in solution. Using
a process known as density gradient ultracentrifugation, the solution is spun in a centrifuge
at 200,000 rpm over the course of several days to separate CNTs according to diameter
(Figure 3.2).1 Extracting the proper layer of CNTs from the density gradient yields highpurity semiconducting CNTs with a relatively uniform distribution of CNT diameters.1

Figure 3.2. Density gradient ultracentrifugation is used to separate CNTs according to diameter
and size with larger diameter CNTs settling toward the bottom. Image adapted from [1].
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A special procedure is used to deposit CNTs across the source-drain channels of
each sensor array (see Appendix D for a full description of the process). Approximately
140 µL of 98% semiconducting CNT solution from NanoIntegris is pipetted onto the
source-drain regions on each chip and placed in a humid environment for 30 minutes
(Figure 3.3). A fraction CNTs gradually self-assemble onto the substrate while the
humidity prevents the solution from evaporating too quickly. This procedure is designed
to yield a relatively uniform CNT network of an appropriate density (Figure 3.4). The
residual CNT solution is washed away with isopropanol to remove residual surfactant and
then again with deionized water to rinse away the isopropanol. The substrate is then
annealed at 165°C on a hotplate for one hour to improve the contact between the CNTs and
the electrodes, effectively lowering the electrode contact resistance.

Figure 3.3. A sensor array is placed inside an enclosed volume together with a hot water
container to humidify the environment. CNT solution is deposited across the FET channel
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regions (outlined in red). The humidity prevents the solution from evaporating while the CNTs
gradually accumulate onto the substrate.

Figure 3.4. Scanning electron microscope images of two representative NTFET channels reveal
disordered CNT networks forming conductive pathways from source to drain electrodes
positioned above and below.

A similar procedure is used to functionalize the NTFETs with single-stranded DNA
of a particular base sequence (see Appendix E for a full description of the process). Ten
customized DNA oligomers are purchased from Invitrogen (Carlsbad, CA), each a 21- or
24-base oligomer of randomized sequences (Table 3.1).
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Table 3.1. Ten single-stranded DNA oligomers used to chemically functionalize DNA-NT arrays.
Each oligomer is a randomized sequence of 21 or 24 nucleotides.
Oligomer Name
Seq1
Seq2
Seq3
Seq4
Seq5
Seq6
Seq7
Seq8
Seq9
Seq10

Base Sequence
GAGTCTGTGGAGGAGGTAGTC
CTTCTGTCTTGATGTTTGTCAAAC
GTACGGACTGTGAATGCGCGTTAG
CCCGTTGGTATGGGAGTTGAGTGC
GCGCATTGGGTATCTCGCCCGGCT
GTATCTAGAGCGGGCGGGTACTCC
AAACAAATCTAATAATACTTCCCA
AGTTCGGCATGTGGAAACTCCTTC
CGCCTAGAGGTCAAGCGTGGTTGC
TGAAAGTGGGAAGCGACACGATGG

The DNA is diluted to 100 µM in deionized water, aliquoted, and stored in a -20°C freezer
until use. One aliquot of each sequence is thawed and a 2 µL droplet is carefully pipetted
onto each of ten source-drain regions on a DNA-NT array (Figure 3.5). As before, the array
is placed in an enclosed humid environment for 30 minutes, allowing the DNA oligomers
to settle out of solution and adsorb onto the CNT surfaces. The droplets are then removed
from the substrate using compressed nitrogen.

Figure 3.5. Ten groups of source-drain regions are functionalized with one of ten oligomers of
single-stranded DNA. 2 µL droplets are carefully pipetted onto each region, allowing the DNA to
gradually settle out of solution onto the CNT network on the substrate. This yields a DNA-NT
hybrid structure only several nanometers in thickness.

35

3.1.3 Electrical Characterization of NTFET Arrays
DNA-NT arrays are characterized by measuring current-gate voltage (I-VG)
characteristics using a FormFactor MPS150 probing station. Conductive silver paint is
applied to the underside of the array to serve as a back-gate contact. The array is placed on
a metal stage to which is a gate voltage is applied. A customized probe card from Amprobe
(Everett, WA) is used to interrogate each contact electrode, routing source-drain currents
to a Keithley 6485 picoammeter as VG is swept from -20 V to +20 V with a fixed sourcedrain bias of 0.1 V. Normally, currents converge towards a particular on-state current for
increasingly negative VG and tend towards a near-zero off-state current for positive VG
(Figure 3.6a). The overall quality of each array is assessed based on distributions of DNANT on-state currents and on-off ratios. Ideally, on-state currents are significantly larger
than the noise threshold and generally do not exceed 100 µA.
A measure of a DNA-NT’s sensitivity to changes in its electrostatic environment is
𝑑I

the transconductance, 𝑔𝑚 = 𝑑V . Chemical gating due to adsorbed VOCs effectively shifts
G

VG from its nominal value which changes the device current by ∆I ≅ 𝑔𝑚 ∆VG . VG is fixed
such that |𝑔𝑚 | is maximized for the greatest number of DNA-NTs (Figure 3.6b).
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Figure 3.6. (a) I-VG curve for a single DNA-NT shows the relationship between the device current
and the applied gate voltage. The diagonal green line indicates the steepest slopes in the I-VG
curve, indicating the gate potential (𝐕𝑮 = −𝟏𝟒𝐕) at which the corresponding device current is
maximally sensitive to variations in local charge environment. (b) I-VG characteristics for all 100
devices from the same sensor array. All DNA-NT transconductances are maximized for gate
potentials between 𝐕𝑮 = −𝟏𝟒𝐕 and 𝐕𝑮 = −𝟏𝟎𝐕.

3.2 Experimental Procedure

A home-built vapor delivery system is utilized to expose sensor arrays to headspace
VOCs from up to five samples at a time while simultaneously measuring device currents
in real time (Figure 3.7a). Low viscosity fluids, such as propionic acid or dimethyl
methylphosphonate, can be placed inside gas bubblers in which headspace VOCs are
pushed out a side arm by bubbling nitrogen from beneath the liquid level (Figure 3.7b).
Blood plasma samples have much higher viscosity and are available in low volume (1 mL
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or less), so they are instead loaded into two-neck round-bottom flasks (Figure 3.7c). Due
to the relatively low vapor pressures of plasma VOCs at room temperature, the flasks are
placed in a 50 °C hot water bath to increase the VOC headspace concentration. Micro stir
bars are included with fluid samples to further promote the release of dissolved VOCs.
High purity compressed nitrogen gas is delivered to the sample flasks or bubblers to carry
the headspace VOCs to a stainless steel sensor chamber housing a DNA-NT array. The
chamber is simultaneously humidified at a fixed relative humidity with water vapor
generated from a bubbler filled with deionized water to enable VOC adsorption onto the
DNA binding sites. The chamber is fitted with an intake and exhaust outlet and is open
from atop to allow placement of a DNA-NT array inside (Figure 3.7d). An acrylic lid fits
over the top of the chamber and is compressed against an O-ring with screws to prevent
gas leaks. The lid is equipped with feed-through pogo pins that make electrical contact with
each DNA-NT, routing current outputs to a National Instruments PXI-2535 switching
matrix used to cycle through each output to be individually measured by a Keithley 6485
picoammeter. The base of the chamber is charged to the desired gate voltage using a
Keithley 617 electrometer. The associated flow rates are regulated using six MKS 1179
computer-controlled mass flow controllers (MFCs), one for each of the five samples and
the sixth for the water bubbler. The various components are connected together with ¼”
Teflon tubing. Portions of the tubing are heated using a heating tape to prevent VOC
adsorption inside the lines. Three-way solenoid valves (ASCO Valve 8320G202) are used
to select the VOC headspace of one sample to be measured at a time. These valves are
actuated electronically via 120VAC solid state relays that are controlled with a computer.
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A LabVIEW program is used to automate the proceedings of the experiment once it has
been set up. The program adjusts MFC flow rates and switches valve states according to a
flow recipe, a precompiled set of instructions that synchronize with a timetable. The
software also controls bias and gate voltages applied to the sensor array and records sourcedrain currents from the picoammeter. This level of automation allows the system to run for
many hours without user input.

Figure 3.7. (a) Schematic overview of the vapor delivery system. Compressed nitrogen is used
as a carrier gas to deliver VOCs in the headspaces of samples (S1 – S5) to a sensor chamber
housing a DNA-NT array. The chamber is humidified with water vapor to enable VOC interaction
with the DNA. Teflon tubing is used to connect the various components together. The gas flow
rates are regulated using mass flow controllers (MFCs) controlled automatically using a
computer program. The samples are heated in a hot water bath to promote the generation of
VOCs. The tubing between the samples and the sensor chamber is also heated (red outline) to
prevent VOC condensation inside the lines. Computer-controlled valves (yellow structures) are
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used to select headspace VOCs from one sample to be measured at a time. (b) Two gas bubblers,
one filled with deionized water for hydration (front). (c) Round-bottom flasks containing blood
plasma (pale yellow regions) are heated in a hot water bath. Magnetic stirring rods (circled in
red) are included to agitate the plasma. (d) Sensor chamber fitted with contact pins to read out
currents from the array of 100 DNA-NTs inside. Three screws compress the top acrylic surface
against an O-ring, preventing VOCs from leaking outside.

3.3 Data Acquisition Protocol and Data Processing
The protocol for taking measurements includes a pulse phase, in which a DNA-NT
array is exposed to a mixture of target VOCs and water vapor diluted in nitrogen gas, and
a refresh phase, where the mixture is replaced with a stream of nitrogen at the same relative
humidity (RH) and total flow rate (Figure 3.8a). The purpose of the refresh is to carry away
residual analytes from the sensor chamber, allowing the DNA-NT currents to recover to
their baseline value. DNA-NT conductances vary significantly from device to device,
hence the distribution of baseline currents can span several orders of magnitude (Figure
3.8b). However, fractional current responses to target VOCs are found to be comparable –
hence, responses are generally reported as fractional current shifts from baseline, ∆I/I0 .
DNA-NT baseline currents are not constant with time, but rather drift in response to
changing ambient conditions. We account for this drift by fitting a baseline to each pulse
measurement using linear interpolation (Figure 3.8c). The fractional current response for
each DNA-NT is then computed as:
∆𝐼 𝐼𝑀𝑒𝑎𝑠𝑢𝑟𝑒𝑑 − 𝐼𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒
=
× 100%
𝐼0
𝐼𝐵𝑎𝑠𝑒𝑙𝑖𝑛𝑒
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(3.3.1)

Baseline-fitted responses from all DNA-NTs functionalized with the same sequence of
DNA are averaged together to produce a representative response for that sequence (Figure
3.8d). Variations on the mean value of ∆I/I0 due to sources of random error are nominally
reduced by a factor of 1/√𝑛 when averaging responses from n DNA-NTs, thus revealing
the advantage of devoting many DNA-NTs to each DNA sequence.

Figure 3.8. (a) A single DNA-NT is exposed to a series of two-minute pulses of propionic acid
mixed with nitrogen at 33% relative humidity (RH). After each pulse, the DNA-NT is flushed with
nitrogen at the same RH for two minutes, allowing the current to recover. The concentration of
propionic acid vapor is incrementally increased after every other pulse from 62 ppm to 3100 ppm
with each increase yielding larger associated responses. (b) Responses from the device in (a)
(shown in red) are compared to those of 16 other DNA-NTs from the same array (black). Currents
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are plotted on a logarithmic scale to show that the fractional responses across all devices are
comparable, even though the magnitudes of baseline currents span several orders of magnitude.
(c) The current response curve from (a) is baseline-fitted using linear interpolation to account for
baseline drift. (d) ∆𝐈/𝐈𝟎 for all 17 devices (red traces) with their average superimposed (black).
The average fractional response exhibits high signal-to-noise ratio.
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CHAPTER 4: Early-Stage Detection of Ovarian Cancer

This chapter presents the use of our e-nose technology to screen blood plasma
samples for volatile indicators of ovarian cancer. Samples were collected from patients
with a malignant form of ovarian cancer, those suffering from benign ovarian lesions, and
healthy age-matched women. DNA-NT sensor arrays were exposed to headspace VOCs of
each sample. The ensuing sensor responses were processed using statistical analysis tools
which revealed the sensor platform’s capacity to differentiate between metabolic VOCs
characteristic of healthy individuals and of those suffering from ovarian cancer.
Section 4.1 proposes a motivation for developing a reliable screening test for
ovarian cancer, particularly for early-stage cancer when treatments are the most effective.
Currently, there are no accepted screening tests for ovarian cancer for women of average
risk. Clinical procedures that reveal ovarian tumors usually do so in the late stages of cancer
when it is often too late to save the life of the patient. Furthermore, these tests exhibit high
false positive rates which puts many patients through unnecessary treatment that causes
significant risks for the patient. Remarkably, several studies have shown that sniffer dogs
can be trained to differentiate between VOCs from blood plasma and other bodily fluids
collected from cancer-suffering patients and healthy individuals. E-nose sensor platforms
based on highly sensitive nanomaterials also show promise in this application, particularly
for detection of early-stage cases where VOC biomarker concentrations are extremely low.
Section 4.2 describes experiments involving blood plasma samples procured from
(1) patients suffering from malignant ovarian lesions, (2) patients with benign tumors, and
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(3) age-matched healthy controls. Initial experiments involved three pools of plasma
samples representing the malignant, benign, and healthy groups. A DNA-NT was
functionalized with four different DNA oligomers and then exposed to headspace VOCs
from the pools. The sensor groups produced diversified responses to the VOCs with some
groups demonstrating promising differentiation between VOCs associated with malignant,
benign, and healthy groups. Additional measurements were conducted using a DNA-NT
functionalized with all ten DNA oligomers to probe headspace VOCs from plasma
collected from 58 individual people. Of these, 21 had a malignant form of ovarian cancer,
16 suffered from a benign from of cancer, and 21 were healthy controls. A special
experimental protocol was developed specifically for measuring plasma VOCs to ensure
reproducibility and signal quality of DNA-NT responses. Once all 58 samples were
measured, the 10-channel DNA-NT responses were dimensionally reduced using linear
discriminant analysis (LDA) yielding well-separated response distributions for the healthy,
benign, and malignant groups.
Section 4.3 discusses predictive modeling based on machine learning algorithms to
enable association of DNA-NT response data with healthy or diseased individuals.
Classifier models based on four machine learning algorithms – LDA, support vector
machine (SVM), k-nearest neighbors, and random forest – were constructed using the
plasma response data as inputs. Each classifier was evaluated based on predictive accuracy
and robustness using two different cross-validation techniques. All four classifiers
demonstrated high validation accuracies and relatively low false-positive rates, signifying
good progress towards a reliable and practical screening technology for ovarian cancer.
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4.1 An Interdisciplinary Effort Towards Reliable Ovarian Cancer
Screening

Ovarian cancer is the fifth leading cause of cancer deaths in United States women.
In 2020 alone, an estimated 13,940 women will have died from ovarian cancer while the
number of new diagnoses is projected at 21,750.1 This staggering death toll is largely due
to a complete lack of screening methods for accurate and early detection of the disease.
The symptoms of ovarian cancer are diverse, non-specific, and commonly mistaken for
those of other diseases such as various gastrointestinal illnesses.2 More than 80% of
diagnoses are associated with late-stage ovarian cancer at which point treatments are no
longer effective – as a result, roughly 70% of patients with late-stage ovarian cancer die
within 5 years.2 On the other hand, if discovered early, ovarian cancer can be treated
effectively with a 90% survival rate.3 Any practical test that can more successfully detect
ovarian cancer in its early stage could significantly increase patient survivability.
Modern medical diagnostics are largely based on some form of visualization,
auscultation, or palpation. Currently, discoveries of ovarian tumors are largely achieved
using some form of medical imaging and clinical laboratory tests. Ultrasound and cancer
antigen 125 (CA-125) blood tests were once proposed as screening tests for ovarian
cancer.4 Ultrasound imaging attempts to image tumor masses around a patient’s ovaries
while CA-125 blood tests can identify individuals that have either healthy or elevated levels
of the CA-125 protein which could indicate the presence of cancer. Unfortunately, both
techniques suffer from high false positive rates. Ultrasound cannot distinguish tumors from
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noncancerous masses and there are many noncancerous conditions that also increase levels
of CA-125 in blood such as endometriosis and pelvic inflammatory disease. As such,
neither technique is considered reliable screening techniques for ovarian cancer.5
In previous centuries, olfaction also played a vital role as doctors would often make
diagnoses based on their own personal senses of sight, touch, and smell. From an
evolutionary point of view, olfaction serves as a mechanism for social animals that
provides a means of communicating information about an individual to others of the same
species. A diseased individual will sometimes give off a foul odor, causing alarm to its
surrounding company. Unfortunately, a human’s sense of smell is largely inferior to other
animals’, and with the emergence of positron emission tomography, ultrasound, liquid
biopsy and other powerful medical aids, olfaction-based medical practices have been
falling by the wayside. Only recently have researchers begun revisiting screening strategies
based on olfaction.6-7 There have been reports of pet dogs behaving differently around their
owners who were later diagnosed with some form of cancer.6, 8 It is believed that this
reaction was triggered by the dogs’ ability to detect minute abnormalities in the VOC
content of bodily odors given off by their owners.8 Though seemingly miraculous, there
exist scientific theories that offer explanations for remarkable behavior. One such theory
is that the metabolic byproducts due to cell division differ significantly between tumor cells
and their healthy counterparts since tumor cells multiply more rapidly and have a higher
metabolic rate. Some of these byproducts are VOCs that are absorbed into the blood stream
and distributed to other parts of the body where they can appear in other bodily fluids such
as sweat, saliva, urine, or tears. Another explanation for this apparent change in VOC
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content from bodily fluids is due to an immune response to the presence of cancer rather
than the cancer itself. Numerous studies have validated canines’ ability to detect VOC
biomarkers associated with a variety of cancers including breast6, bladder9, and ovarian8
from breath, urine, and blood samples, respectively.
A collaboration between the University of Pennsylvania and the Monell Chemical
Senses Center in Philadelphia is using three approaches to research the differences in odor
signature in bodily fluids between women diagnosed with malignant ovarian cancer, those
identified as having benign ovarian tumors, and age-matched healthy individuals. The first
approach, directed by Dr. Cynthia Otto at the Penn Working Dog Center, involves training
dogs to identify blood samples as healthy or non-healthy (i.e. cancerous) by sniffing the
VOCs emitted by blood samples collected from individual people. The second approach
focuses on using gas chromatography / mass spectrometry (GC/MS) to analyze the
chemical makeup of characteristic VOCs of cancerous blood samples versus healthy
samples. The third approach is to develop a laboratory platform based on DNA-NT arrays
for ovarian cancer screening which is the scope of this dissertation.
Samples for this work were procured by our collaborator Professor Janos Tanyi
through the Ovarian Cancer Center at the University of Pennsylvania Hospital. To ensure
VOCs were retained for analysis, all samples were spun at 3000 rpm for ten minutes at 4°C
and then stored frozen at -80 °C. The samples were later defrosted on ice and then divided
into aliquots of 500 µL. The aliquots were distributed among all collaborators so that all
samples could be analyzed using the sniffing dogs, GC/MS, and DNA-NT e-nose methods.
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The aliquots were refrozen at -30 °C and stored until needed. For experiments, samples
were thawed and then immediately analyzed by the DNA-NTs.

4.2 DNA-NT Measurements of Headspace VOCs from Blood Plasma
4.2.1 Initial Investigations Using Pooled Plasma
The ovarian cancer project was initiated by Dr. Nicholas Kybert, a former Johnson
PhD student. A preliminary experiment involved three pools of blood plasma procured
from women with a malignant form of ovarian cancer, women suffering from benign
tumors, and healthy age-matched controls. Each pool contained 500 µL of plasma from ten
individual women. The pools were loaded into three separate 25 mL two-neck roundbottom flasks that were each placed in a 50 °C hot water bath to promote VOC generation.
Each pool was also agitated with a micro stir bar to further encourage the release of VOCs.
The flasks were connected to the other e-nose components with Teflon tubing wrapped
with a heating element to inhibit VOC condensation. An early-generation array of 80 DNANTs was functionalized with four distinct sequences of DNA (Seq1, Seq2, Seq4, and Seq5)
to probe the VOC headspaces of the three pools.
Once the samples were brought to temperature, a 30-minute waiting period was
issued to allow VOCs to accumulate within the headspaces of the flasks. The sensor array
was then exposed to VOCs from the malignant pool diluted in nitrogen at a 1:4 volume
ratio. Because plasma is mostly composed of water, the nitrogen component of the mixture
was humidified to 100% relative humidity (RH). The malignant pulse was sustained for
two minutes, after which the DNA-NTs were refreshed with 100% RH nitrogen for two
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additional minutes. VOCs from the benign and healthy pools were measured in the same
manner. Three measurements were completed for each pool.
Exposure to plasma VOCs caused a negative shift in DNA-NT currents (Figure
4.1). Repeated measurements of each sample were closely reproduced and the signal-tonoise ratios of averaged responses were well above the noise threshold. Seq1 sensors
demonstrated a remarkable ability to discriminate between the plasma headspaces of each
pool (Figure 4.1a). Notably, responses to healthy VOCs were consistently the largest in
magnitude and those associated with malignant pool were always the smallest with the
benign responses in between. Unlike Seq1, Seq4 responses to malignant, benign, and
healthy VOCs were far less diverse and hardly demonstrated any ability to distinguish any
of the pools. The remaining sensors demonstrated some differentiation capacity, though
neither were as pronounced as Seq1 (Figure 4.1b). Overall, the diversity of responses from
only four sensor types suggested a strong potential of DNA-NT arrays to discriminate
between ovarian cancer biomarkers in a complex plasma headspace.

Figure 4.1. (a) Averaged sensor responses (∆𝑰/𝑰𝟎 ) of 21 Seq1 and 18 Seq4 DNA-NT devices
exposed to VOCs from the cancerous, benign, and control pools. Three cycles of responses for
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each pool are shown to show strong reproducibility between repeated measurements. Seq1
responses demonstrate a strong ability to differentiate between the pools with the healthy pool
showing the largest responses, malignant showing the smallest, and the benign in between. In
contrast, Seq4 responses show almost no ability to distinguish them. (b) Responses to all four
DNA sequences exhibit a diversified olfaction signature of the pooled samples.

4.2.2 Measurement of Blood Plasma from Individuals
Follow-up measurements were conducted on additional plasma samples collected
from 58 different people. Of these, 21 had a malignant form of ovarian cancer, 16 suffered
from a benign from of cancer, and 21 were healthy controls. Six of the malignant samples
were from women suffering from Stage I or Stage II cancer while the remaining were from
women with Stage III or IV cancer. As before, each sample was loaded into 25 mL roundbottom flask and heated in a 50 °C water bath. DNA-NT arrays were coated with all ten
DNA oligomers listed in Table 3.1 (including the four used in the pooled experiment) and
then exposed to VOCs according to the same two-minute pulse and two-minute refresh
protocol used previously (Figure 4.2a). Furthermore, responses from all sensor types
formed three clusters corresponding to the malignant, benign, and healthy groups (Figure
4.2b). These clusters overlapped significantly, indicating that effective discrimination of
VOCs would require the combined efforts of multiple DNA-NT sensor types. This
variation of responses within each cluster is attributed to biological differences between
individual people.
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Figure 4.2. (a) Average of 9 Seq1 DNA-NT responses exhibit differentiation of headspace VOCs
from plasma samples derived from three healthy individuals, a patient with benign ovarian
cancer, and a patient with a malignant form of cancer. Three cycles of measurements are shown
to demonstrate the reproducibility of responses between repeated measurements. (b) Seq1
responses for all 58 samples reveal clustering of data within malignant, benign, and healthy
groups save for one malignant outlier (indicated by the blue arrow). Data points are displayed on
an arbitrary horizontal axis to aid in visualizing overlapping points. The clusters overlap
significantly, indicating that further data analysis techniques are needed to improve
discrimination of each group.

Improved separation between the clusters was achieved using linear discriminant
analysis (LDA), a predecessor to many advanced machine learning techniques used today
(Figure 4.3). LDA is a supervised learning algorithm that requires prior knowledge of data
classification. Hence, the data was supplemented with healthy, benign, and malignant class
labels which were provided as additional inputs for LDA. No distinction was made to treat
early-stage and late-stage cancer samples at this time. Projections of data onto the first
linear discriminant (LDA1) revealed three well-separated distributions corresponding to
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each class. Remarkably, all early-stage malignant samples were well-situated within the
malignant distribution, suggesting a strong potential for reliable early-stage detection using
DNA-NT sensors.

Figure 4.3. DNA-NT responses to headspace VOCs from plasma collected from 58 individuals are
projected onto the first linear discriminant (LDA1) computed by linear discriminant analysis
(LDA).

4.2.3 Headspace Regulation of Plasma Samples
Repeated measurements of plasma headspace VOCs caused a significant
systematic depletion of DNA-NT baseline currents over the course of each experiment
(Figure 4.4a). It is not fully understood why this occurs with VOCs associated with blood
plasma as this phenomenon has not been observed for VOCs from other media. The current
hypothesis is that this is caused by gradual accumulation of one or more “sticky” molecular
components of the plasma headspace that are reluctant to desorb from the DNA-NTs,
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resulting in only partial recovery of device currents after each refresh and thus attenuating
DNA-NT responses over time (Figure 4.4b).

Figure 4.4. (a) A single DNA-NT sensor is exposed to a series of sixteen exposures to headspace
VOCs from one blood plasma sample to demonstrate attenuation of both the baseline current
and the response levels. The start times of the first four exposures are marked by the brown
arrows. (b) The average current responses of all ten Seq6 devices also demonstrates signal
attenuation and deteriorating signal-to-noise ratios over time.

A special experimental protocol was developed to reduce the attenuation of DNANT currents due to plasma VOC exposure. Typically, sample VOCs are allowed to
accumulate within the headspace of the corresponding container between measurements
(i.e. whenever the system is busy measuring a different sample). This was altered
specifically for measuring plasma by constantly delivering nitrogen to all samplecontaining flasks throughout all stages of the experiment, effectively reducing the
associated headspace VOC concentrations. Three-way solenoid valves were used to direct
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the flow of sample VOCs either to the sensor chamber to be measured or out a separate
exhaust path (Figure 4.5).

Figure 4.5. Modified gas-delivery setup for measuring headspace VOCs from blood plasma
samples. Nitrogen gas is continuously delivered to all samples throughout the experiment while
three-way solenoid valves (yellow structures) direct each flow either to the sensor chamber to
be measured or out a separate exhaust. This decreases the headspace concentrations of plasma
VOCs which slows the rate of DNA-NT response attenuation.

This technique markedly improved the reproducibility of DNA-NT responses to plasma
VOCs, nearly eliminating the systematic signal drift observed earlier (Figure 4.6). In
addition, signal-to-noise ratios remained high above the noise threshold even though the
overall concentration of VOCs was reduced.
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Figure 4.6. Nine Seq6 DNA-NTs were exposed to six cycles of measurements of five plasma
samples in sequence. The samples were measured in the same order for each cycle. The
responses demonstrate significantly improved reproducibility and a high signal-to-noise ratio.

4.3 Sample Classification Using Machine Learning

4.3.1 Sample Classification Based on Cross-Validation
Predictive modeling based on pattern recognition algorithms was performed on the
chemical sensor data to enable association of DNA-NT responses with healthy or diseased
individuals. Initially, an LDA-based classifier was constructed with the ovarian response
data using the Scikit-learn package for the Python programming language.10 The
robustness of the classifier was verified using two cross-validation techniques: Leave One
Out Cross-Validation (LOOCV) and stratified k-fold cross-validation. Cross-validation is
often used to test for biased training of a dataset in machine-learning applications.
LOOCV is designed to test whether or not a single new data point would be
correctly categorized by the classifier. This is simulated by building the classifier using all
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but one of the samples in the database. The classifier is then used to predict the identity of
the left-out sample. This process is repeated until each individual sample in the database
has been validated. For the ovarian data set, 55 of the 58 samples were correctly identified,
yielding a validation accuracy of 95% (Table 4.1). Both misclassified samples were false
negatives with one malignant sample identified as benign and one benign sample identified
as healthy. All early-stage samples were correctly classified as malignant.

Table 4.1. Results of LOOCV on the entire ovarian dataset. 55 of the 58 samples were correctly
classified, yielding a validation accuracy of 95%. The three misclassified samples were all false
negatives with two malignant samples identified as benign and one benign identified as healthy.
The misclassified malignant sample was from a late-stage cancer patient.

CLASSIFIED (LOOCV)

ACTUAL

Malignant
Benign
Healthy

Malignant
19
0
0

Benign Healthy
2
0
15
1
0
21

Stratified k-fold cross-validation is a derivative of k-fold cross-validation in which
a dataset is randomly partitioned into k equal-sized subsets (Figure 4.7). One partition is
chosen as the validation data while the remaining k – 1 subsets are used as the training data.
This process is repeated until all partitions have been validated once. Due to the element
of randomness, it is common practice to repeat the entire k-fold cross-validation process
multiple times so that the validation results converge towards a representative set of values.
k-fold cross-validation does not take the classification of each data point into account which
can be problematic for relatively small data sets since there is a significant chance of obtain
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training sets that are underrepresented by one or two of the sample groups. A solution is to
stratify the k partitions such that each subset comprises an equal fraction of data points
from each class, ensuring that the mean response for each class is approximately equal in
all partitions.

Figure 4.7. Using the stratified k-fold cross-validation technique, the malignant, benign, and
healthy data are each randomly shuffled and then partitioned into four equal-sized subsets.
Three subsets from each class are combined to form the training set while the remaining form
the validation set. The process is repeated until all data points have been validated exactly once.

Stratified k-fold cross-validation was used to partition the ovarian plasma database
into four subsets, using 75% of the data as the training set with the remaining 25% as the
validation set. This process was performed 10,000 times to obtain convergent validation
estimates. On average, 3.76 samples out of 58 were misclassified, corresponding to a
validation accuracy of 94%. The overall false-positives rate remained low at less than
0.1%. A detailed summary of the results is presented in Table 4.2.
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Table 4.2. Stratified k-fold cross-validation was performed 10,000 times on the ovarian database.
The percentages indicate the number of correctly or incorrectly classified samples for each
corresponding class. The overall validation accuracy was 94% while the overall false positives
rate was less than 0.1%.

CLASSIFIED (stratified
k-fold)
Malignant

ACTUAL Benign
Healthy

Malignant
86.0%
0%
0%

Benign Healthy
13.6%
0.4%
93.8%
6.2%
0.5%
99.5%

The classification performances of three additional learning algorithms, each more
sophisticated than LDA, were also investigated. Support vector machine (SVM), k-nearest
neighbors (KNN), and random forest were each used to construct new classifiers based on
the combined dataset. Each algorithm was trained and tested according to LOOCV (Table
4.3) and repeated stratified k-fold (Table 4.4) cross-validation methods. For the latter, 90%
of the samples were used for the training set and the remaining 10% for the test set. As
before, this was repeated 10 times so that each sample was in the testing set exactly once.
The entire process was repeated 1000 times, shuffling the data each time to form
independent trials. Again, each independent trial was stratified such that approximately
equal proportions of malignant, benign, and healthy data were used for the training and
testing sets for all repeats. In all cases, high validation accuracies were achieved. Despite
being the least sophisticated algorithm, LDA performed the best in terms of overall
accuracy, scoring around 95% for both LOOCV and k-fold. The other classifiers achieved
accuracies of approximately 90%. This is perhaps due to the fact that SVM, KNN, and
random forest are designed for larger datasets, in which case they may have been
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overfitting the 58 ovarian responses and compromising the validation accuracies as a result.
Remarkably, the number of false positives were consistently low in all cases with all
algorithms successfully classifying 100% of all six early-stage cancer samples with the
exception of random forest which misclassified one as benign.

Table 4.3. Validation performances for Leave-One-Out Cross-Validation (LOOCV) for LDA, SVM,
KNN, and random forest classification algorithms. LDA classified all samples with the highest
accuracy (95%) with zero false positives.

19/21
17/21
17/21

False
Positives
0
1
0

False
Negatives
3
5
5

18/21

3

4

Classifier

Overall

Healthy

Benign

Malignant

LDA
SVM
KNN
Random
Forest

55/58 (95%)
52/58 (90%)
53/58 (91%)

21/21
20/21
21/21

15/16
15/16
15/16

51/58 (88%)

19/21

14/16

Table 4.4. Repeated stratified k-fold evaluation of the same four classification algorithms using
10 bins and 1000 repeats.

18.6/21.0
17.1/21.0
16.8/21.0

False
Positives
0.1
1.0
0.0

False
Negatives
3.4
4.9
5.2

18.2/21.0

2.4

3.8

Classifier

Overall

Healthy

Benign

Malignant

LDA
SVM
KNN
Random
Forest

54.5/58 (94%)
52.1/58 (90%)
52.8/58 (91%)

20.9/21.0
20.0/21.0
21.0/21.0

15.0/16.0
15.0/16.0
15.0/16.0

51.7/58 (89%)

19.5/21.0

14.0/16.0

4.3.2 Classification Based on Receiver Operating Characteristics

The classification performance of LDA was also verified with receiver operating
characteristics (ROCs). Normally, ROCs are used to characterize the predictive accuracy
of a two-class system. Because there are three classes for our database (i.e. healthy, benign,
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and malignant), three ROC curves were generated using one class as the “positive” signal
and the other two as the “negative” signal. ROC outputs were based on stratified k-fold
cross-validation using training / validation splits of 90% / 10% (Figure 4.8a) and 75% /
10% (Figure 4.8b). In each case, the validation accuracies for the healthy and malignant
groups were nearly 100% while the benign group was validated with nearly 90% accuracy.
Though the benign accuracy fell by 3% relative to the prior LDA-based k-fold results, the
malignant accuracy rose by about 10%, marking a significant improvement for malignant
classification. Furthermore, the nearly identical results reported by both sets of train /
validation splits confirm the stability of the overall dataset.

Figure 4.8. (a) ROC curves generated from stratified k-fold cross-validation using 10,000 repeats
and a training / validation split ratio of 90% / 10%. (b) The procedure is repeated using a split
ratio of 75% / 25%. The accuracies reported in both (a) and (b) are nearly identical.

In conclusion, the successful differentiation of VOCs associated with healthy and
cancerous individuals indicates the strong potential of DNA-NT sensor arrays as a
screening method for ovarian cancer. Particularly promising is the consistently accurate
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classification of early-stage samples which would place DNA-NTs above other clinical
trials. Such results support the proposed advantage of early-stage cancer screening based
on VOC biomarker detection over other techniques that lack the necessary sensitivity,
possibly due to lack of signal. In the case of liquid biopsy, which attempts to collect
circulating tumor DNA (ctDNA), there is necessarily a lack of ctDNA within early-stage
cancer patients since the tumors at this point would be relatively small. On the other hand,
it is plausible that even early-stage cancer can cause a response from the host’s immune
system that is reflected in the VOC contents found within the patient’s bodily fluids or
body odor. Another clinical advantage of DNA-NT screening is the apparently low rate of
false positives boasted by the pattern-recognition algorithms. In a real clinical setting,
avoiding a false positive diagnosis would mean preventing unnecessary treatments like
chemotherapy that are often accompanied by troublesome side-effects. Overall, the results
signify the promise for this technology in comparison to currently established techniques
and motivate further development to manifest an effective screening technique for ovarian
cancer screening.
The performance of this technique could be enhanced by improving the various
components of the e-nose system. To date, we have only explored chemical responses in
the scope of ten distinct DNA sequences. By investigating new DNA oligomers, we could
discover other sequences that offer orthogonal chemical sensing information that is not
accessed by the original sequences. Unlike the current set of DNA oligomers, which were
chosen randomly, new oligomers could be engineered to target particular VOC biomarkers
for ovarian cancer discovered by GC/MS. Furthermore, testing new DNA oligomers allows
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us to pick and choose the most successful sequences for this application. We intend to
redesign our sensor array to increase the number of distinct sensor types from 10 to 100.
This will increase the “chemical resolution” with which we probe the volatile headspaces
of each plasma sample. It will also allow us to test a greater number of DNA oligomers at
once in order to efficiently discover optimal sequences. We also aim to increase our sample
size to better represent the chemical vapor signatures from various populations. This will
enable us to utilize more specialized machine-learning methodologies to further improve
the overall classification accuracy.
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CHAPTER 5: Assessment of DNA-NT Performance for
Remote Monitoring Applications

This chapter presents potential uses of DNA-NT arrays in remote monitoring
applications such as pollution detection and monitoring of agricultural produce. Various
performance characteristics of DNA-NTs were investigated with a series of experiments
designed to simulate certain complex environmental conditions related to such
applications.
Section 5.1 motivates several desired qualities of ideal environmental chemical
sensors, including low detection limits, detection of dilute targets in the presence of a
complex background, fast chemical response readouts, and long lifetime.
Section 5.2 discusses experiments involving a freshly made DNA-NT array
exposed to various concentrations of 2,6-dinitrotoluene (DNT). The array demonstrated
sensitivity to parts-per-billion (ppb) concentrations of DNT. The experiment was repeated
with exposure times reduced from two minutes to one minute. DNA-NT responses to the
DNT were diminished but still visibly apparent after some signal processing,
demonstrating high sensitivity and fast response times of our sensors.
Section 5.3 discusses follow-up experiments involving the same array, this time
exposed to DNT mixed with dimethyl methylphosphonate (DMMP) to simulate a complex
background. DNA-NTs successfully distinguished 152 parts-per-million (ppm) DMMP
from 152 ppm DMMP mixed with 149 ppb DNT, indicating sensitivity to a dilute target
even in the presence of a 1000-times concentrated background. The fresh DNA-NT array
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was replaced with another identical array that was prepared four months prior and the
complex background experiment was repeated. Responses to DNT and DMMP mixtures
were expectedly diminished, possibly due to partial denaturing of the sensing material.
Nevertheless, the older array was also able to discriminate between mixtures with and
without DNT. Thus, the DNA-NTs performed desirably in terms of sensitivity, selectivity,
and longevity, making them promising candidates for a wide range of environmental
applications.

5.1 Introduction

There is a strong desire for chemical vapor sensors that can operate in real-world
settings with numerous potential uses in agricultural1-2, military,3-4 and environmental
monitoring applications.5-10 Examples include assessment of ripeness or vitality of crops
and produce, remote detection of mines in a warzone, and detection of pollutants in the
atmosphere. In each case, chemical sensors must be able to identify target molecules in a
complex chemical background. Furthermore, unlike laboratory settings where relative
concentrations of VOC mixtures can be controlled precisely, the volatile backgrounds in
real-world settings are constantly fluctuating which makes successful classification of
VOCs more challenging. In practice, commercial sensors are often expected to collect vast
amounts of data for extended periods of time, sometimes on the order of weeks or months.
Because of this, sensors with low-power consumption and long lifetimes are preferred. Fast
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measurement readouts are also coveted so as to capture as many VOC binding events as
possible.
A series of experiments was initiated in collaboration with Rohinton Mehta’s group
at X Development (Mountain View, CA) to assess the performance of our DNA-NTs in
real-world environments. Five separate experiments were conducted within the laboratory
using the e-nose system to simulate various environmental conditions. DNA-NT
performance was evaluated based on the following desired characteristics: (1) detection of
low concentrations of VOC analytes down to parts-per-billion levels; (2) detection of
fractional changes of analyte concentration in the presence of a concentrated complex
background; (3) fast responses to analytes; and (4) long-lasting devices that can remain
functional for weeks or months.

5.2 Parts-per-billion Detection of 2,6-Dinitrotoluene

The first experiment sought to demonstrate parts-per-billion (ppb) sensitivity of the
DNA-NTs. 2,6-Dinitrotoluene (DNT) was chosen as the target analyte due to its relatively
low vapor pressure (5.67 ∙ 10−4 Torr).11 Roughly 10 mL of solid DNT powder was placed
in a gas bubbler and allowed ample time to generate headspace volatiles. A fresh DNA-NT
array with 80% device yield was prepared the day before the experiment. The array was
initially exposed to two-minute pulses of DNT mixed with nitrogen at three different
concentrations: 14.9 ppb, 149 ppb, and a fully saturated concentration of 746 ppb (Figure
5.1a). Each pulse was followed by a two-minute refresh with pure nitrogen. Water vapor
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was not included in the mixture to remove any doubt that the ensuing responses were
caused by DNT alone. Exposure to DNT caused positive current shifts in DNA-NT
currents, which was expected due to prior investigation.12 Responses to 149 ppb and 746
ppb DNT were easily resolved. Responses to 14.9 ppb DNT were less profound and not
easily resolved without additional data processing. Hence, all DNA-NT currents were
baseline-fitted and then smoothed using 7-point boxcar averaging to improve signal-tonoise. This revealed visibly apparent responses to 14.9 ppb DNT.

Figure 5.1. (a) A day-old DNA-NT array was exposed to 2,6-dinitrotoluene (DNT) at various
concentrations. Current responses are shown for a single Seq4 DNA-NT (blue). Responses are
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clear for 149 ppb and 746 ppb concentrations of DNT, but less so for 14.9 ppb. A fitted current
baseline (red) was subtracted from the raw current trace to reveal responses to 14.9 ppb DNT.
(b) Average current responses for five DNA-NT sensor types (Seq1 through Seq5). The other five
sensor types (Seq6 through Seq10) produced visually similar results and are not shown.
Responses to 14.9 ppb DNT are small, yet visibly apparent. 149 ppb and 746 ppb responses are
easily resolved. All averaged current responses were smoothed using 7-point boxcar averaging.

The experiment was repeated with exposure and periods reduced from two minutes
to one minute. DNA-NT currents were again baseline-fitted and smoothed using boxcar
averaging. The response magnitudes were predictably reduced due to the lower exposure
time. Nevertheless, Seq4 and Seq5 current responses were clearly resolved for all target
concentrations while the other sensor groups also evidenced some detection capacity for
14.9 ppb and 149 ppb DNT (Figure 5.2). These results demonstrate the desirably high
sensitivity and fast response capabilities of DNA-NTs.

Figure 5.2. DNT exposure times are reduced from two minutes to one minute. The responses are
smaller as expected. Only Seq4 and Seq5 responses demonstrate apparent detection of 14.9 ppb
and 149 ppb DNT.
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5.3 Detection of DNT Target in Complex Background

The second experiment simulated detection of a target analyte in a complex
background. The same day-old DNA-NT array was initially exposed to a mixture of DNT
with dimethyl methylphosphonate (DMMP), a compound known to have a significantly
larger vapor pressure (0.579 Torr) than DNT.13 The relative concentrations of DNT and
DMMP were fixed at 149 ppb and 152 parts per million (ppm), respectively, thus creating
a 1000-times diluted target-to-background mixture. After a one-minute exposure, the
DNA-NTs were refreshed using 0% relatively humid (dry) nitrogen. This was followed by
an exposure to 152 ppm DMMP devoid of DNT in the mixture. DMMP is known to cause
negative shifts in DNA-NT currents,12 and since the DMMP was more concentrated, the
responses to both types of pulses were expectedly negative. The DNA-NT responses were
baseline-fitted and smoothed as before. This revealed that the current responses of the
DNT-containing pulses were shifted slightly positive relative to responses to the DMMP
background alone (Figure 5.3). Given that DNT exposures elicit positive responses, this
result suggested that the presence of highly diluted DNT was indeed detected in the 1000times concentrated complex background.
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Figure 5.3. DNA-NT responses to the 152 ppm DMMP + 149 ppb DNT mixture are superimposed
with responses to only DMMP for comparison. All responses were smoothed using 7-point
boxcar averaging. Solid lines represent the mixture and dashed lines are for the suppressed
mixture. A slight relative positive shift in response is observed for the mixture containing DNT,
suggesting that the DNA-NTs detected the lack of DNT molecules which are known to evoke
positive current responses.

The DNT detection in complex background experiment was repeated using a fourmonth-old DNA-NT array in place of the fresh array. The old array had not been used in
any prior experiments and was merely kept in a plastic petri dish stored in air after it was
fabricated. Up to this point, we had never observed responses of DNA-NT arrays more
than a few weeks old and thus, it was not known whether the months-old array would
reproduce the results from the previous experiment or if denaturing of the DNA had
compromised its sensing capabilities. Despite its age, the array boasted a device yield of
78% which was near that of the fresh array. As before, a one-minute exposure to 149 ppb
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DNT with 152 ppm DMMP background was issued, followed by a one-minute exposure
to 0 ppb DNT and 152 DMMP. The DNA-NTs were again refreshed with dry nitrogen in
between each exposure. This cycle of measurements was repeated two more times and the
average responses to each mixture were compared (Figure 5.4). The overall response
magnitudes for the older array were diminished by roughly a factor of ten, suggesting that
some denaturing of the sensing material had occurred. Nevertheless, a relative positive shift
was observed for responses to mixtures containing DNT, thus reproducing the results of
the fresh array. This result suggests a long-term shelf life of DNA-NTs projected on the
order of months.

Figure 5.4. The complex mixtures experiment was repeated using an DNA-NT array stored in air
for four months. All responses were smoothed using 7-point boxcar averaging. The response
profiles for 149 ppb DNT (solid line) and 0 ppb DNT (dashed line) represent averages of the three
responses to each mixture. The overall response magnitudes for the older array were diminished
by roughly a factor of ten, suggesting that some denaturing of the sensing material had occurred.
However, the same relative positive shift was observed for responses to mixtures containing
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DNT, confirming that the months-old DNA-NT array was able to reproduce the results of the fresh
array.

For certain applications, it may not be feasible to refresh the DNA-NTs with
nitrogen after every exposure. To simulate the constant presence of a complex background,
the latter experiment was repeated once more using a 152 ppm DMMP mixture as the
refresh instead of dry nitrogen. The months-old array was exposed to alternating mixtures
of 149 ppb DNT in DMMP background and plain DMMP background (Figure 5.5). Slight
negative current shifts were observed in the absence of DNT in the mixture, validating the
trend observed in the previous experiments and thus confirming the capability of DNANTs to detect a dilute target despite the lack of a clean refresh.

Figure 5.5. DNA-NT responses to pulses of 149 ppb DNT in 152 ppm DMMP background refreshed
with 152 ppm DMMP instead of pure nitrogen. All responses were smoothed using 7-point boxcar
averaging. The first pulse overresponded significantly, possibly due to unregulated buildup of
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the DMMP headspace, and was therefore ignored. For the remaining responses, small yet
apparent negative current shifts are observed in the absence of DNT in the mixture.

In conclusion, our DNA-NTs demonstrated promising performance in terms of
sensitivity, fast response, long lifetime, and ability to detect a dilute target in a highly
concentrated complex background. Though X Development did not disclose their
particular interests in this technology, it is conceivable that DNA-NT arrays can be used
for long-term monitoring of crops or mounted on robotic devices programmed to roam
warzones or other potentially hazardous environments in search of explosives or chemical
weapons. Sensor performance can be further optimized according the specific application
by tuning DNA-NT affinities towards the desired targets via specially engineered DNA
sequences. Further performance enhancements may be realized by using more
sophisticated baseline-fitting algorithms and noise reduction techniques.
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CHAPTER 6: DNA-NT Screening for SARS-CoV-2
Based on Human Sweat

In this chapter, we discuss the deadly implications of the new coronavirus SARSCoV-2 that spread rapidly across the world and the need for efficient and accurate screening
of large populations for the COVID-19 disease. Early identification of infection would
allow medical experts and government officials to take effective preventative measures,
such as enforcing strict quarantine regulations for densely populated urban centers that are
at high risk of an outbreak.
Section 6.1 introduces a pilot study initiated by our collaborator Dr. Cynthia Otto
involving human sweat samples provided by individuals who had tested positive for
COVID-19 (CoV+) as well as those who had been confirmed as COVID-negative (CoV-).
The aim was to train scent detection dogs to discriminate between VOCs associated with
the CoV+ and CoV- groups. All samples were shared with the Johnson Group for a
complementary investigation using DNA-NT arrays.
Section 6.2 describes experiments involving DNA-NT measurements of headspace
VOCs from 30 sweat samples: fifteen from COVID-positive subjects and fifteen from
COVID-negative individuals. The ensuing DNA-NT responses were processed using linear
discriminant analysis (LDA) which revealed strong discrimination between the CoV+ and
CoV- groups. An LDA-based binary classifier was constructed using estimated normal
distributions associated with the two groups. The classifier demonstrated degrees of
sensitivity and specificity which are comparable to what is currently reported for reverse
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transcription polymerase chain reaction (RT-PCR), one of the established screening
techniques used for COVID-19 today. A receiver operating characteristic (ROC) curve was
also generated using the CoV+ and CoV- distributions from which a 99% classification
accuracy was estimated for the LDA binary classifier. These compelling results suggest
significant promise for reliable screening based on DNA-NT sensor arrays and motivate
further investigation.

6.1 Introduction

A new strain of coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), emerged in Wuhan, China during the winter of 2019 and spread rapidly
around the world.1 Those infected with the virus develop coronavirus disease 2019
(COVID-19) with potentially severe or deadly outcomes.2 This is the third coronavirus
outbreak within the past twenty years and is by far the most infectious to humans with over
58 million reported cases and nearly 1.4 million deaths worldwide as of November 15,
2020.1-2 The United States leads the world in both figures with over 12 million cases and
250,000 deaths.1 Though there has been progress towards a vaccination for preventing the
illness, none have yet been approved by the U. S. Food and Drug Administration.3
Furthermore, developing accurate screening tests is challenging due to the novelty of
COVID-19. Current detection approaches utilize reverse transcription polymerase chain
reaction (RT-PCR) as well as antigen and antibody tests.4 Reports of sensitivity for RTPCR tests are largely uncertain, ranging from about 70% to 98%, while specificities are
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estimated at roughly 95%.5 The accuracies of antigen and antibody tests are even less
certain as each suffers from high false negative rates.4 A sensing technology that can permit
effective and efficient screening of large populations would help reduce the rate at which
COVID-19 spreads, particularly in airports, hospitals, and other potentially densely
populated areas.
A pilot study was initiated by our collaborator Dr. Cynthia Otto at the Penn Vet
Working Dog Center, University of Pennsylvania, with the aim of training scent detection
dogs and using DNA-NT arrays to discriminate between human sweat samples from
COVID-19 positive (CoV+) subjects and COVID-19 negative (CoV-) individuals. Dr. Otto
established an online system through which volunteers could apply to donate sweat
samples through the mail. Only volunteers who had been tested for COVID-19 were
eligible for selection. Each volunteer was provided a brand new 100% cotton T-shirt and
was given instructions to wear it to sleep for one night. The T-shirt would absorb sweat
generated from the volunteer throughout the night. Each shirt was isolated inside a Ziploc
bag for 24 hours before being returned to Dr. Otto in order to extinguish any lingering
active viruses inhabiting the samples.6 All shirts were transported and handled in a BSL2
biosafety hood to satisfy University of Pennsylvania regulations for COVID-19 research.
Due to their high sweat content, portions from the sleeves, back, and chest areas were cut
from each shirt and placed in individual glass jars for VOC preservation. Samples were
split evenly and shared between the Otto and Johnson research groups.
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6.2 DNA-NT Measurements of Human Sweat Samples

DNA-NT sensor arrays functionalized with ten DNA oligomers listed in Table 3.1
were used to measure headspace VOCs from fifteen COVID positive (CoV+) and fifteen
COVID negative (CoV-) T-shirt samples. Strips of cloth were cut from the T-shirt sleeves
using scissors cleaned with isopropanol and loaded into separate 25 mL round-bottom
flasks. The samples were heated to 50 °C and were allowed 15 minutes to generate
headspace VOCs. These were subsequently delivered to a ten-channel DNA-NT array for
two minutes at a time using 67% RH nitrogen. Small yet distinguishable responses to the
sample VOCs were observed (Figure 6.1).

Figure 6.1. Average responses to eight Seq9 DNA-NT sensors exposed to headspace VOCs from
two CoV+ and one CoV- T-shirt sleeve samples. Two cycles of measurements are shown to
demonstrate signal reproducibility. The responses are small compared to those associated with
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blood plasma, which are typically on the order of 10%. Nevertheless, the signal-to-noise ratios
of the response averages are comparable to those observed for plasma.

The ten-channel DNA-NT response data was processed using linear discriminant
analysis (LDA). Response projections onto the first discriminant revealed strong separation
between the CoV+ and CoV- groups (Figure 6.2). Given the lack of overlap between the
clusters, a classification boundary line between them could easily be imagined that would
result in perfect binary classification of all data. For a more informed estimation of the
classifier’s diagnostic accuracy, Gaussian distributions were approximated for each cluster
based on their respective means and standard deviations in order to simulate overlap
between the groups. The false positive (false negative) rate was calculated by dividing the
area of the overlapped region of the CoV+ (CoV-) distribution by the area of the nonoverlapped region.

Figure 6.2. LDA projections of DNA-NT responses to fifteen CoV+ and fifteen CoV- T-shirt
samples are represented as colored triangles along the first linear discriminant (LDA1) with
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associated Gaussian distributions based on the computed means and standard deviations of
each cluster. The dashed line through the intersection between the curves indicates a binary
classification boundary which defines the true positive, false positive, true negative, and false
negative regions (labeled as TP, FP, TN, and FN, respectively).

The sensitivity and specificity for the binary classifier were also estimated based
on the Gaussian distributions from Figure 6.2. Sensitivity measures the fraction of CoV+
cases that were correctly identified as positive while specificity measures the fraction of
CoV- cases that were correctly classified as negative (6.2.1):
𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦 =

𝑇𝑃𝑅
𝑇𝑃𝑅 + 𝐹𝑁𝑅

(6.2.1a)

𝑆𝑒𝑙𝑒𝑐𝑡𝑖𝑣𝑖𝑡𝑦 =

𝑇𝑁𝑅
𝑇𝑁𝑅 + 𝐹𝑃𝑅

(6.2.1b)

where TPR, TNR, FPR, and FNR are the true positive, true negative, false positive, and
false negative rates, respectively. The calculated DNA-NT sensitivity was 93.5% and the
selectivity was 95.8% which is comparable to the most optimistic estimates for RT-PCR
tests. The diagnostic accuracy of the binary classifier based on the two Gaussian
distributions was also estimated using a receiver operating characteristic (ROC) curve
(Figure 6.3). The area under the curve indicated a 99% probability of correctly
distinguishing CoV+ from CoV- data.
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Figure 6.3. Receiver operating characteristic for the estimated normal distributions from Figure
6.2. The area under the curve indicates a 99% probability of correctly distinguishing CoV+ and
CoV- data.

In conclusion, DNA-NT sensors demonstrated a strong capacity to differentiate
between headspace VOCs from human CoV+ sweat and CoV- sweat in this initial proofof-concept investigation. The success of the DNA-NT sensors is particularly impressive in
this case because they were immediately adaptable to discriminating between VOCs
associated with such a new disease, alluding to the flexibility of the technology.
Advantages of this e-nose approach include speed of development, on-site prompt testing
potential, guaranteed safety to both the patient and the caretaker, and relatively low cost of
deployment. Furthermore, because only human sweat is needed as a specimen, this
approach is non-intrusive and compatible with other testing approaches.
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These compelling results motivate further development of an e-nose approach to
screening populations for the COVID-19 disease. In order to build further acclaim for this
screening method, we plan to increase our sample database up to 400 CoV- and 200 CoV+
individuals. As is discussed in previous chapters, we also have the opportunity to improve
our selection of DNA oligomers to further increase the discrimination power of the DNANTs, perhaps by targeting specific characteristics of biomarker molecules discovered by
GC/MS that are associated with COVID-19. Finally, the success of LDA-based data
processing suggests the possibility of using more sophisticated machine learning
algorithms that may improve the performance of this e-nose based diagnostic.
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Chapter 7: Summary, Conclusions and Future Work

In this work, progress was made in developing an e-nose system based on DNANT arrays capable of screening individuals for ovarian cancer and COVID-19 using human
blood plasma and sweat, respectively. In addition, DNA-NTs were shown to have desirable
attributes in terms of parts-per-billion (ppb) limits of detection, the ability to detect low
concentrations of target VOCs in the presence of a highly concentrated background, fast
responses on the order of seconds, and lifetimes on the order of months. The successes
enjoyed by the DNA-NTs suggest significant promise for their utility in disease diagnostics
as well as various environmental monitoring applications such as pollution detection.
These vapor sensors possess exquisite sensitivity that has only recently become
available due to the technological breakthroughs and advancements in the fields of
nanotechnology and bioengineering and rise up to the challenge posed by early-stage
disease detection where very small concentration of one or several compounds is present.
Furthermore, despite the fact that the identities of relevant VOC compounds are often not
completely known, DNA-NT arrays have demonstrated a desirable ability to differentiate
between informative vapor species using the same principles that govern the discrimination
capabilities of mammalian olfaction systems found in nature.
In addition, DNA-NTs enjoy numerous attributes that make them ideal candidates
for hospital use or remote monitoring of various environments. Because they are fastresponding, cost-efficient, and easy to use by non-technical personnel, e-nose systems
based on DNA-NTs are ideal for on-site prompt testing. These characteristics are clear
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advantages over expensive and highly complex analytical techniques such as gas
chromatography / mass spectrometry (GC/MS) which are cumbersome and suffer from
slow readouts. Given their function of probing compounds in the vapor phase, DNA-NTs
are also generally non-intrusive as the possibility of direct contamination of the sensor (or
contamination of the sample from the sensor) is reduced.
The fabrication of vapor sensor arrays is simple and can also be customized and
tailored towards specific applications by choosing the DNA oligomers that work best for
detecting certain molecules. Thus, as researchers develop a more complete understanding
of the volatile metabolites in bodily tissues or fluids that indicate the presence of particular
diseases of interest, the DNA-NT arrays can be evolved for improved screening
performance.
In medical practice, clinical screening always yields false positives and negatives
due to biological variations between individuals and countless other sources. Both forms
of experimental error are of clinical concern. False negatives occur when a screening fails
to identify the presence of a condition. This is especially problematic for diseases like
ovarian cancer that can only be treated reliably in the early stages. A false negative in this
case would often be fatal as the cancer would be able to metastasize unbeknownst to
caretakers and patients alike until it is too late to treat the patient. With such high stakes,
false negatives reduce the confidence of the medical community that the screening
technology is worthwhile. False positives have dramatic consequences as well. False
positives will put healthy individuals through unnecessary follow-up examinations such as
biopsies. These tests are often harmful to the patients that receive them, and the overall
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process can cause a great deal of needless anxiety. Moreover, biopsies are arduous and
expensive procedures, and too many false positives will put strain on hospitals that have
limited resources in terms of personnel, equipment, and funds.
The DNA-NT arrays have already demonstrated promising performance in terms
of false positives and negatives. However, this technology has yet to see extensive testing
in a real hospital setting. To curtail some of the worry surrounding false predictions, DNANTs can be combined with other techniques that could provide orthogonal information to
increase the probability of identifying important features in samples that would ultimately
lead to improved classification performance. This is easily imaginable, as vapor-phase
chemical sensing is unlikely to interfere with other sensing modalities in terms of
contamination.
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APPENDIX
Appendix A: Basic Mathematical Foundations of Machine Learning
Algorithms

Appendix A.1: Principal Component Analysis
The general procedure of PCA is to represent a data set with a basis that will best
distinguish significant parameter correlations from signal noise. We start by imagining a
data set acquired from a 10-channel NTFET array exposed to VOCs from n different trials.
We define 𝑿 = {𝑥1 , 𝑥2 , … 𝑥10 } as the set of ten-dimensional NTFET outputs where the
column vector 𝑥1 represents the Seq1 responses, 𝑥2 represents the Seq2 responses, and so
on. Important trends are easily revealed when the signal-to-noise ratios (SNRs) of the
responses are high, and much less so when the SNRs are low. The response signals are
associated with the variances of 𝑥1 , 𝑥2 , … 𝑥10 . Meanwhile, NTFET responses are also
strongly correlated because they are highly cross-sensitive. This is an indication that much
of the information in the output data is redundant. Thus, we consider the covariances
between the 𝑥𝑖 parameters represented in the following covariance matrix:

𝑣𝑎𝑟(𝑥1 )
𝑐𝑜𝑣(𝑥1 , 𝑥2 )
1
𝑐𝑜𝑣(𝑥
,
𝑥
)
𝑣𝑎𝑟(𝑥2 )
2 1
𝑆𝑋 =
𝑿𝑿T = [
⋮
𝑛−1
𝑐𝑜𝑣(𝑥10 , 𝑥1 ) 𝑐𝑜𝑣(𝑥10 , 𝑥2 )
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𝑐𝑜𝑣(𝑥1 , 𝑥10 )
𝑐𝑜𝑣(𝑥2 , 𝑥10 )
]
⋱
⋮
⋯
𝑣𝑎𝑟(𝑥10 )
⋯

We now want to represent 𝑿 in a basis more suitable to revealing only the most
important information with as few parameters as necessary. To do this, we apply a linear
transformation on 𝑿:
𝑷𝑿 = 𝒀
where 𝑷 is an orthonormal matrix. This transformation essentially rotates the
representation of 𝑿 to a new set of axes encoded in the rows of 𝑷. The best choice of 𝑷
associates only a few principal components with high measures of SNR – that is to say,
maximizing the response signals, measured by the variances, and minimizing redundancy,
measured by covariances. This is achieved if the covariance matrix 𝑆𝑌 of 𝒀 = 𝑷𝑿 takes a
diagonal form:
𝑆𝑌 =

1
1
1
(𝑷𝑿)(𝑷𝑿)T =
𝒀𝒀T =
𝑷(𝑿𝑿𝑻 )𝑷𝑻
𝑛−1
𝑛−1
𝑛−1

Since 𝑿𝑿𝑻 is a symmetric matrix, it can be diagonalized by 𝑿𝑿𝑻 = 𝑽𝑫𝑽𝑇 . Here, the
columns of 𝑽 are the eigenvectors of 𝑿𝑿𝑻 and 𝑫 is a diagonal matrix whose elements are
the eigenvalues of 𝑿𝑿𝑻 . Setting 𝑷 = 𝑽𝑇 simplifies our expression:
𝑆𝑌 =

1
1
1
𝑷(𝑽𝑫𝑽𝑇 )𝑷𝑻 =
𝑷(𝑷𝑻 𝑫𝑷)𝑷𝑻 =
𝑫
𝑛−1
𝑛−1
𝑛−1

In this way, the procedure for PCA is reduced to solving a generalized eigenvalue for 𝑿𝑿𝑻 .

Appendix A.2: Linear Discriminant Analysis
We imagine a data set where each data point, 𝑣 𝑖 , represents ten response averages
(Seq1, Seq2, and so on). We define the basis 𝑽 ∈ ℝ such that each 10-dimensional data
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point {𝑣 1 , 𝑣 2 , 𝑣 3 , 𝑣 4 , … 𝑣 𝑁 } ∈ 𝑽 where N is the total number of data points. Our mission is
to find a transformation that maps 𝑽 → 𝒀 where 𝒀 is the basis with maximized class
separation. For simplicity, we assume there are only two classes with N1 data points in
Class 1 and N2 data points in Class 2. We relate 𝑦 to 𝑣 by the transformation 𝑦 = 𝑤 𝑇 𝑣
𝑤1
𝑣1
𝑤2
𝑣2
where 𝑣 = .. and 𝑤 = .. . To maximize the separation between class distributions,
.
.
[𝑤𝑚 ]
[𝑣𝑚 ]
we will need two properties: (1) the relative positions of each distribution in space and (2)
the degree of spread within each distribution.
Starting with first property, let 𝜇𝑖 be the centroid of distribution of the ith class
represented in the 𝑽 basis:
𝑁𝑖

1
𝜇𝑖 = ∑ 𝑣𝑗
𝑁𝑖
𝑗=1

Transforming this to the 𝒀 basis, we obtain:
𝑁𝑖

𝑁𝑖

𝑁𝑖

𝑗=1

𝑗=1

𝑗=1

1
1
1
𝜇̃𝑖 =
∑ 𝑦𝑗 = ∑ 𝑤 𝑇 𝑣𝑗 = 𝑤 𝑇 ∙ ∑ 𝑣𝑗 = 𝑤 𝑇 𝜇𝑖
𝑁𝑖
𝑁𝑖
𝑁𝑖
We now define a measure of the “offset” between distributions:
(𝜇̃1 − 𝜇̃2 )2 = (𝑤 𝑇 𝜇1 − 𝑤 𝑇 𝜇2 )2 = 𝑤 𝑇 (𝜇1 − 𝜇2 )(𝜇1 − 𝜇2 )𝑇 𝑤 = 𝑤 𝑇 𝑺𝑩 𝑤 = 𝑺̃𝑩
Here, 𝑺𝑩 is the between-class scatter matrix for samples in the 𝑽 space while 𝑺̃𝑩 is same
matrix represented in the 𝒀 basis.
Now, for the second property, we define the following metric of within-class
scatter:
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𝑁𝑖

𝑠𝑖 2 = ∑(𝑥𝑗 − 𝜇𝑗 )(𝑥𝑗 − 𝜇𝑗 )

𝑇

𝑗=1

or alternatively,
𝑁𝑖
2

𝑠̃𝑖 = ∑(𝑦𝑗 − 𝜇̃𝑗 )(𝑦𝑗 − 𝜇̃𝑗 )

𝑇

𝑗=1

We can define a within-class scatter matrix 𝑺𝒊 for each class as the following:
𝑁𝑖

𝑁𝑖
𝑇

𝑇

𝑠̃𝑖 2 = ∑(𝑦𝑗 − 𝜇̃𝑗 )(𝑦𝑗 − 𝜇̃𝑗 ) = ∑ 𝑤 𝑇 (𝑥𝑗 − 𝜇𝑗 )(𝑥𝑗 − 𝜇𝑗 ) 𝑤 = 𝑤 𝑇 𝑺𝒊 𝑤
𝑗=1

𝑗=1

Then the total within-class scatter for the entire data set is defined as the sum of these terms
for each class:
𝑠̃1 2 + 𝑠̃2 2 = 𝑤 𝑇 (𝑺𝟏 + 𝑺𝟐 )𝑤 = 𝑤 𝑇 𝑺𝑾 𝑤 = 𝑺̃𝑾
where 𝑺𝑾 and 𝑺̃𝑾 are the complete within-class scatter matrices for the entire data set in
bases 𝑽 and 𝒀, respectively.
The transformation 𝑦 = 𝑤 𝑇 𝑣 the between-class separation relative to the overall withinclass scatter is accomplished by finding a 𝑤 that maximizes the following:
𝐽(𝑤) =

|𝜇̃1 − 𝜇̃2 |2
𝑠̃1 2 + 𝑠̃2 2

𝑤 𝑇 𝑺𝑩 𝑤
= 𝑇
𝑤 𝑺𝑾 𝑤

Solving for 𝑤, we differentiate both sides and set the result equal to zero:
𝑑
𝑑 𝑤 𝑇 𝑺𝑩 𝑤
𝐽(𝑤) =
(
)=0
𝑑𝑤
𝑑𝑤 𝑤 𝑇 𝑺𝑾 𝑤
With some algebra manipulation we obtain the following:
𝑺−𝟏
𝑾 𝑺𝑩 𝑤

𝑤 𝑇 𝑺𝑩 𝑤
−( 𝑇
) 𝑤 = 𝑺−𝟏
𝑾 𝑺𝑩 𝑤 − 𝐽(𝑤)𝑤 = 0
𝑤 𝑺𝑾 𝑤
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We are now faced with a generalized eigenvalue problem where 𝑺−𝟏
𝑾 𝑺𝑩 = 𝜆𝑤. Here, the
eigenvalue 𝜆 = 𝐽(𝑤). We can finally solve for 𝑤:

This is the general solution for the optimized basis for maximizing the separation between
two classes. The result can be generalized to any number of classes with some more effort.
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Appendix B: Fabrication Procedures for DNA-Functionalized NTFET
Arrays
Appendix B.1: Photolithography Process
Deposit 15nm of Al2O3 on standard Si/SiO2 wafer. Then follow the steps below:

1.) Pre-bake
Dehydration bake: ~150°C, ~ 2mins.

2.) Primer
Spin PMGI: 4000 rpm, 45s, 500 rpm/s
Bake at 210°C for 5 minutes

3.) Photoresist
Spin S1813: 5000 rpm, 45s, 500 rpm/s
Bake at 100°C for 2 minutes

4.) UV Light Exposure
Use a hard contact procedure with manual alignment. Exposure dose is 120 mJ/cm2. Use
the mask-aligner camera to make sure the common source electrode for column 10 is not
clipped by the edge of the silicon wafer.
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5.) Development
Immerse substrate in MF-319 developer for around 30-60s. Use a pipette to agitate and
disperse dissolving resist away from surface. The features of the pattern should gradually
appear and change color due to the changing thickness of the resist. Once the surface is a
uniform dark purple, remove the wafer from the developer and immediately rinse with
water for a few minutes. Blow-dry with a nitrogen gun when the wafer is sufficiently
cleaned.

6.) Evaporation
Normally evaporate 5 nm Cr / 40 nm Au

7.) Lift-off
Use R1165 remover to lift-off leftover resist. Leave the wafer soaking overnight and then
heat the remover to 60°C. Use a pipette to agitate the solvent so that every last bit of
residual photoresist is dissolved. Sometimes sonication is needed to resolve finer features.
When the desired pattern is fully resolved, transfer the wafer to an acetone bath for 10 min
and then to an isopropanol bath for 10 min. After blow-drying, bake the wafer at 250°C for
1 hour.
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Appendix B.2: CNT Deposition

1. Acquire one large petri dish (bottom and cover), one small petri dish (cover only),
and one glass slide. Place glass slide and small cover in the large bottom.
2. If sonication is needed, pipette desired volume of CNT solution in a 1.5 mL aliquot
vial and place vial in a foam “floater.” Place in the small sonicator and sonicate for
desired duration.
3. Choose array(s) for CNT deposition and blow off with N2 gas. Place chips on the
glass slide.
4. Start boiling DI water.
5. Drop-cast roughly 130 – 140 µL of CNT solution for each array.
6. Pour boiling water into small cover. Cover everything with the large cover and set a
timer for 30 min.
7. When the timer goes off, remove the top cover and the water container. Pour
isopropanol directly into the large bottom so that the chips are fully immersed in
solvent.
8. Set a timer for 15 minutes. Agitate the IPA bath every 3 minutes.
9. Transfer to a water bath. Be sure to prevent the chips from drying out during the
transfer by spraying each chip with water from a squirt bottle while it is exposed to
the air.
10. Set timer for 5 minutes.
11. Repeat steps 9 and 10 two more times.
12. Blow each chip dry with N2 gas.
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13. Set each chip on a hot plate set at 165ºC. Set a timer for 1 hour.
14. Remove chips from hot plate. Once cool, apply silver paint to the underside of each
chip.
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Appendix B.3: DNA Deposition
1. Acquire materials- 1 large petri dish (bottom and cover), 1 small petri dish (cover
only), and 1 glass slide. Place glass slide and small cover in the large bottom.
2. Thaw aliquots of desired DNA sequences (usually I use Seq1 through Seq10)
3. Choose array for DNA deposition and blow off with N2 gas. Place the chip on the glass
slide.
4. Start boiling DI water.
5. Pipette roughly 1.8 – 1.9 µL of DNA onto the regions shown below:

Seq1
Seq2
Seq3
Seq4
Seq5

Seq6
Seq7
Seq8
Seq9
Seq10

6. Fill the small petri dish with hot water and close the cover of humidity bath.
7. Set a timer for 30 minutes.
8. Remove the chip from the humidity bath. Use the nitrogen gun to carefully blow the
five leftmost droplets off the left side of the chip one at a time (corresponding to Seq1 –
Seq5 in the diagram). Then blow off the remaining five droplets simultaneously.
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Appendix C: Tabulated Ovarian Plasma Responses

Current responses to VOCs from the 58 individual plasma samples. Each response
value represents the percent variation from baseline, ΔI/I0, for all sensors of a given sensor
type. The sample set consists of 21 healthy samples, 16 benign samples, and 21 malignant
samples, of which five were from women with Stage I/II ovarian cancer. Variations in
average responses within each class is believed to be caused by biological variations
between individuals.

Sample #

Seq1

Seq2

Seq3

Seq4

5
3
13
15
7
14
9
18
17
B10
B16
D21
C7
C24
C30
D8
D26
D31
D36
D56
D59

-3.84
-4.74
-3.26
-3.04
-3.38
-1.97
-1.87
-1.65
-1.72
-2.91
-3.08
-2.71
-2.75
-2.97
-3.12
-3.39
-3.03
-3.13
-2.69
-2.60
-3.25

-0.60
-1.71
-0.90
-0.95
-0.72
-1.12
-1.26
-1.11
-1.08
-1.17
-1.10
-0.96
-1.03
-1.07
-1.04
-1.03
-1.02
-1.06
-0.91
-0.98
-1.20

-2.24
-3.44
-2.00
-1.91
-2.12
-0.81
-0.77
-0.83
-0.69
-1.79
-1.76
-1.40
-1.61
-1.28
-1.57
-1.58
-1.69
-1.81
-1.62
-1.71
-1.93

-1.79
-3.21
-1.82
-1.90
-1.84
-0.88
-0.79
-0.81
-0.75
-1.33
-1.65
-1.50
-1.49
-1.24
-1.57
-1.43
-1.73
-1.67
-1.48
-1.45
-1.61

54
53
58
64

-2.18
-2.27
-2.33
-1.32

-1.57
-1.80
-1.91
-1.21

-1.33
-1.38
-1.38
-0.57

-1.09
-1.18
-1.27
-0.50

Seq5

Seq6

Seq7

Seq8

Seq9

Seq10

-2.17
-3.39
-2.03
-1.45
-2.03
-0.85
-0.75
-0.67
-0.58
-1.84
-1.57
-1.47
-1.60
-1.25
-1.63
-1.62
-1.25
-1.49
-1.45
-1.31
-1.67

-2.26
-2.55
-1.92
-2.36
-2.18
-0.81
-0.84
-0.95
-0.85
-1.57
-1.54
-1.79
-1.93
-1.55
-1.65
-1.64
-1.69
-1.68
-1.36
-1.66
-1.56

-4.31
-6.60
-4.06
-4.45
-4.91
-1.84
-1.84
-1.89
-1.66
-3.47
-4.09
-3.22
-3.69
-2.88
-3.30
-3.28
-3.62
-3.79
-3.75
-3.95
-3.79

-3.37
-4.65
-2.98
-2.99
-2.80
-1.10
-0.94
-1.13
-1.04
-2.00
-2.81
-2.57
-2.21
-2.21
-2.45
-2.59
-2.94
-2.45
-2.21
-2.36
-2.68

-4.45
-5.13
-3.61
-3.19
-4.05
-1.29
-1.24
-1.32
-1.20
-2.68
-2.63
-2.52
-2.99
-3.06
-2.72
-3.12
-2.47
-3.16
-2.50
-2.34
-3.22

-1.24
-1.27
-1.32
-0.42

-0.96
-1.19
-1.17
-0.94

-2.72
-2.70
-2.94
-1.09

-1.95
-2.01
-2.08
-0.98

-2.00
-2.21
-2.06
-1.02

Healthy
-2.95
-7.06
-3.71
-4.42
-3.82
-1.85
-1.36
-1.66
-1.24
-3.68
-3.01
-3.67
-3.38
-3.51
-2.56
-3.18
-3.00
-3.64
-3.47
-2.99
-3.16

Benign
-1.46
-1.24
-2.14
-0.96
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56
H5837
H6032-8
H600111
H613010
H6153-6
H5869
H6019-4
H6044-5
H6057-7
H6145-2
H6151-6

-1.97
-2.19
-2.06

-1.64
-1.69
-1.13

-1.16
-1.12
-1.18

-0.96
-0.98
-1.05

-1.07
-1.30
-1.44

-0.93
-1.05
-0.85

-1.16
-1.15
-1.13

-2.36
-2.14
-2.47

-1.56
-1.61
-1.63

-1.79
-1.68
-1.86

-2.12

-1.59

-1.14

-1.06

-1.48

-0.71

-1.01

-2.37

-1.62

-1.67

-1.89
-1.86
-2.05
-2.08
-2.12
-1.96
-1.94
-2.17

-1.65
-1.63
-1.65
-1.71
-1.48
-1.64
-1.47
-1.69

-1.21
-1.11
-1.22
-1.13
-1.11
-1.17
-1.24
-1.14

-1.05
-0.98
-0.97
-0.89
-1.08
-0.98
-1.13
-0.99

-1.49
-1.32
-1.39
-1.37
-1.48
-1.49
-1.32
-1.19

-1.01
-1.15
-0.99
-0.83
-1.05
-0.84
-0.98
-1.12

-1.08
-1.07
-1.01
-1.14
-1.14
-0.93
-1.11
-1.12

-2.07
-2.45
-2.40
-2.23
-2.33
-2.28
-2.43
-2.39

-1.71
-1.71
-1.70
-1.63
-1.76
-1.53
-1.85
-1.75

-1.84
-1.84
-1.71
-1.89
-1.89
-1.95
-1.63
-1.69

49
46
52
57
50
48
45
66*
68
65
H603514
H591910
H601716
H6133-9
4451-C1210*
H5877*
H592616
H5899*
H60119*
H594010*
H6083-9

-2.25
-6.67
-2.02
-1.39
-1.39
-1.63
-2.21
-2.19
-1.96
-1.9

-1.54
-2.16
-0.95
-0.72
-0.74
-1.60
-2.39
-1.56
-1.29
-2.11

-3.15
-4.40
-2.97
-3.17
-3.55
-0.94
-1.42
-1.08
-1.00
-0.87

-3.33
-7.15
-2.14
-1.88
-1.89
-1.15
-1.59
-1.14
-1.07
-0.96

-2.26
-9.63
-2.07
-2.62
-4.16
-1.36
-2.41
-1.54
-1.58
-1.29

-2.62
-3.97
-2.33
-0.31
-1.04
-0.89
-1.75
-1.16
-1.03
-0.78

-1.10
-6.97
-1.19
-1.85
-2.80
-1.54
-1.17
-1.83
-1.51
-1.46

-4.61
-7.54
-2.83
-2.16
-2.56
-1.84
-2.98
-2.25
-2.14
-2.14

-5.44
-5.30
-3.50
-3.27
-2.23
-1.35
-1.98
-1.62
-1.56
-1.38

-3.87
-7.83
-3.00
-1.74
-2.26
-1.48
-1.80
-1.69
-1.54
-1.46

-2.39

-1.53

-2.07

-2.04

-3.00

-1.64

-1.93

-2.74

-2.92

-2.42

-2.47

-1.61

-2.62

-2.49

-2.53

-1.59

-2.24

-2.65

-2.90

-2.67

-2.24
-2.13

-1.57
-1.44

-2.24
-2.23

-2.28
-1.94

-2.45
-2.55

-1.50
-1.74

-2.04
-2.10

-3.11
-3.28

-3.09
-2.53

-3.11
-2.72

-2.12
-2.26

-1.45
-1.57

-2.20
-2.32

-1.83
-2.23

-2.40
-2.78

-1.72
-1.55

-2.50
-1.97

-3.13
-3.23

-2.75
-2.79

-2.47
-2.50

-2.44
-2.46

-1.49
-1.54

-2.20
-2.35

-1.87
-2.27

-3.41
-3.16

-1.61
-1.82

-2.20
-2.29

-3.27
-3.55

-2.74
-2.91

-2.26
-2.36

-2.59

-1.44

-2.21

-2.44

-2.94

-1.83

-2.18

-3.45

-2.84

-2.55

-2.13
-2.54

-1.56
-1.39

-2.06
-2.27

-2.25
-2.65

-3.36
-3.06

-1.83
-1.99

-2.05
-2.89

-3.11
-3.25

-2.58
-2.78

-2.81
-2.74

Malignant

* Stage I/II ovarian cancer
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